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S ummary
An in vitro preparation of the bovine perfused eye has been used to study the 
mechanisms of action of drugs on intraocular pressure (IOP) in isolation from 
the complicating influence of the cardiovascular system, hormones and central 
nervous system as in most previous reports using the rabbit. This method 
also avoids the necessity to kill animals for experimental purposes and 
provides rapid access to the living tissues for biomedical analysis.
In this model the isolated bovine eye is perfused through the long posterior 
ciliary artery to provide simultaneous monitoring of drug effects on IOP and on 
the ciliary blood vessels.
In this research most of the drugs have been tested by using various routes of 
administration in our effort to provide logical and more understandable 
mechanisms of action for their effect upon IOP. IOP values were measured 
for 60-90 min following drug administration and were compared against similar 
experiments in which water was used as a control.
Results obtained with adenosine and its selective agonists cyclohexyl 
adenosine (CHA), the selective adenosine Ai receptor agonist and N-®-(2-(3,5- 
Dimethoxyphenyl)-2(2-methylphenyl)-ethyl adenosine (DPMA), the selective 
adenosine A2 receptor agonist showed that they produced small transient 
effects on arterial perfusion pressure. Their effects on IOP were insignificant, 
whether inserted into the reservoir as an arterial perfusate solution or when 
injected into the posterior ciliary artery as a bolus injection.
ATP produced a significant effect on both perfusion pressure and IOP when 
injected intra-arterially. The increase in perfusion pressure produced 
immediately after ATP injection probably was due to its vasoconstrictor effect 
on the uveal vasculature. ATP produced a statistically significant dose- 
dependent decline in IOP in a dose range of 300 to 3000nmol. The 
mechanism of action of ATP on IOP is still obscure.
Preliminary experiments with 5-hydroxytryptamine (5-HT) using arterial routes 
indicate that this drug has no effect on perfusion pressure or IOP. On the 
other hand intracameral (I.C) Injection of 5-HT produced a transient increase 
in perfusion pressure and a statistically significant decrease in IOP in a dose 
range of 3 to 30 nmol. lOOnmol 5-HT produced a statistically insignificant 
decrease in IOP, suggesting that 30nmol was the maximum dose of 5-HT to 
produce decreases in IOP.
Doses of 8-hydroxy-2-(di-n-propylamino)-tetralin) (8-OH-DPAT), the selective 
5-HTia receptor agonist, produced an insignificant effect on bovine IOP by the 
arterial routes. I.C 8-OH-DPAT produced no effect on perfusion pressure, but 
significant decline of IOP was produced in a dose-dependent manner.
Single bolus injections of 5-carboxamidotryptamine (5-CT) (20 to 200nmol) 
produced no effect on perfusion pressure, but produced a statistically 
significant dose-dependent decrease in IOP. The conclusion is reached that 
the mechanism by which 5-HT, 8-OH-DPAT and 5-CT reduce IOP is probably 
through increase In the drainage of aqueous humour when these drugs are 
injected by the I.C route.
XI
The enzyme-immuno assay for cyclic AMP was performed to study the effects 
of adenosine, 5-HT and 8-OH-DPAT in bovine ciliary processes (CP) and 
trabecular meshwork (TM) homogenates. The aim of that was to make a 
correlation between the effects of these drugs on cAMP and their effects on 
IOP.
5-HT produced an increase in cAMP synthesis in CP and TM homogenates, 
although this effect was not dose-dependent. 5-HT produced changes in 
cAMP of CP homogenate which were too variable to give any conclusion. The 
conclusion reached is that 5-HT may reduce IOP through increases in cAMP 
synthesis in TM tissue, which may produce a rise in facility of outflow. The 
results for 8-OH-DPAT on cAMP in both TM and CP were too variable to draw 
any meaningful conclusion.
XU
INTRODUCTION
(1-1) GROSS STRUCTURE OF THE EYE
The eyeball is spherical in shape. It is composed of three coats: (1) The outer 
protective layer is made up of sclera posteriorly and cornea anteriorly 
(Berman, 1991). The cornea is the first and the most powerful refractory 
surface of the optical system of the eye (Davson, 1990). (2) The middle coat 
is the most vascularized, pigmented part in the eye. It consists of the ciliary 
body, iris and choroid. The ciliary body is the site of production of aqueous 
humour. It also permits variation of the focus of the eye (accommodation) 
through its attachment to the lens by the ciliary zonules. The blood supply to 
the ciliary body is derived from the ciliary arteries (Bill, 1981). The iris is the 
most anterior portion of the vascular tunic of the eye. it contains circular 
muscle surrounding the pupil and controls its size, thus regulating the amount 
of light entering the eye. The choroid is the highly vascularized part of the 
middle coat. It extends from the ora serrata to the optic nerve. It conducts 
arteries and nerves to the anterior part of the eye. It also supplies nutrition to 
the outer retina by the choriocapillaries (Kllntworth and Landers, 1976). 
Blood vessels in the choroid are highly fenestrated and leaky, like the ciliary 
body. (3)The inner most coat, comprising the retina, contains the essential 
sensory elements responsible for vision (rods and cones) (Cohen, 1981). 
They respond to the visual stimuli and transduce the light into electrical 
signals transmitted along the nerve fibres to the optic nerve and finally to the 
brain (Jackson & Finlay, 1991 ). Within the three coats, are the aqueous 
humour, vitreous humour and the crystalline lens. Internally, the eye has two 
spaces, the larger filling the space between the lens and retina, termed the 
vitreous, and the smaller, between the internal surfôce of the cornea and lens
termed the aqueous humour (Tripathi and Tripathi, 1984). The aqueous 
chamber is itself divided into the anterior chamber (between the anterior 
surface of the iris and the internal surface of the cornea) and the posterior 
chamber (between the posterior surface of the iris and the anterior surface of 
the lens) (Bowman and Rand, 1981). The cornea and lens are avascular 
tissues, they obtain their nutrition from the continuous circulation of the 
aqueous humour containing the dissolved O2 and nutrition, indirectly derived 
from various blood vessels (Seidal, 1918; Coperland & Kinsey, 1950).
Reona
Macula
Optic Nerve
Vitreous
Figurai. 1 Anatomy of the human eye. (Dalas.W.W.W).
(1.2) INTRAOCULAR PRESSURE
Intraocular pressure (IOP) of the eye is of interest to both the physiologist 
and the ophthalmic clinician. To the physiologist IOP is a manifestation of 
those biophysical and biochemical processes that produce and drain the 
intraocular fluids. These processes include passive osmotic pressure and 
active transport. To the ophthalmic clinician IOP is of deep concern because 
abnormally high IOP, a serious medical condition called glaucoma, can lead 
to irreversible blindness.
Pressure within the eye is the highest in the body except for the arterial 
system. The average IOP for the human is about 15mmHg and a range of 22- 
25mm.Hg is "suspiciously" high. All eyes with pressure of 25mm.Hg or 
greater, however, are not necessarily abnormal. The individual variation in 
responses of ocular tissues to elevated IOP is considerable. A patient may 
have continual increases in IOP but wit h none of the other signs of 
glaucoma, such as cupping of the optic disc or change in the visual field. On 
the other hand, normal pressure may continually be recorded in a patient with 
progressive field changes (Moses, 1981).
At constant rates of aqueous humour production, IOP will rise until the 
resistance to outflow is exceeded. When outflow is exactly equal to the rate 
of aqueous humour production, IOP stabilizes at a level determined by these 
variables. Thus the IOP at any given moment is the result of a dynamic 
equilibrium exactly matching aqueous production and the rate of aqueous 
outflow (Hart, 1992).
IOP varies with time of day. It appears to be highest early in the morning and 
lowest in the evening. The variation is about 4mmHg. The patient with 
glaucoma may have a much higher diurnal variation (8 to lOmmHg) than
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does the non-glaucomatous individual, and maximum pressure can occur at 
any time of the day or night.
(1.2.1) MEASUREMENT OF IOP
In the normal eye, intraocular pressure is governed by the relationship 
between the rate of aqueous humour formation and drainage. The rate of 
aqueous humour formation is equal to the rate of drainage and pressure is 
maintained by resistance in the outflow system. Any deviation from the 
normal relationship between inflow and drainage resistance will affect the 
IOP. IOP can be measured in three ways: Palpation, Tonometry and 
Manometry. (1) Digital palpation is the least reliable method and is useful 
only for estimating large deviation from normal. Its use should be restricted to 
eyes with external ocular infections and to uncooperative patients, such as 
infants, where there is contraindication to general anaesthesia.
(2)Tonometric technique: is used almost exclusively in the clinic for 
estimating IOP. Schiotz tonometry, was previously one of the most commonly 
employed clinical means of estimating IOP. It measures corneal indentation 
by a known weight. The variable effects of scleral rigidity decreases the 
accuracy of this method in the presence of conditions such as extreme 
myopia and ocular inflammation. Sources of error from Schiotz tonometry 
include scleral rigidity, a poorly calibrated tonometer, or improper application 
of the tonometer to the cornea. Goldmann (1957) applanation tonometry, is a 
modified method of Schiotz tonometry. This method reduces the force 
needed to applanate or flatten the cornea. At this point the scleral rigidity 
factors are minimised hence increasing the accuracy of this method for 
measuring IOP. Applanation tonometry is widely used by ophthalmologists,
but the equipment is impractical for non ophthalmologists (Leydhecker, 
1985).
All previously discussed tonometers require topical corneal anesthesia. The 
need for a tonometer that could be used without topical anesthetics led to the 
development of the Durham-Langham pneumatonometer( Leydhecker, 1958). 
This is also applanation tonometer because it causes flattening rather than 
indentation of the cornea. The volume of aqueous humour displaced by 
corneal flattening is so small that there is little or no effect on scleral rigidity. 
The manufacturer claims that this method will give true IOP readings when 
applied to the sclera as well as when applied to the cornea. A small 
downward correction must be made, however, when the sclera is used for 
measurment. The problem is that the sclera is covered with soft conjunctival 
and episcleral tissue so that proper applanation is less certain than on the 
cornea. The advantage of applying the tonometer to the sclera instead of to 
the cornea lies in the sclera’s lack of sensitivity; the tonometer may then be 
used without topical anesthesia. It appears that Durham-Langham type of 
tonometers may give more accurate IOP measurements than does the 
Goldmann tonometer when used on diseased, scarred, and/or thickened 
corneas (McMillan and Forster, 1975).
(3) Manometry: this is the most accurate means of measuring IOP. This 
consists of inserting a needle into the anterior chamber and connecting 
the needle by tubing to a sensitive pressure transducer. This method has 
limited clinical use, but it is an extremely accurate procedure in the 
laboratory (Davson, 1984 ).
(1.3) AQUEOUS HUMOUR
Aqueous humour is a transparent fluid contained in the anterior and posterior 
chambers of the eye and is formed by the ciliary epithelium of the ciliary 
processes projecting from the ciliary body. As the aqueous is formed, it 
enters the posterior chamber where it flows in three directions: (1) most of 
the aqueous humour flows forward between the lens and iris and through the 
pupil into the anterior chamber (Patrick and Trevor, 1986). (2) a small 
portion flows into the vitreous to be absorbed in the posterior part of the eye 
and (3) some of the aqueous is apparently reabsorbed at the ciliary body. A 
part from supplying nutrition to the ocular tissues aqueous humour has other 
functions including: supplying the substrates required for normal metabolic 
function of the avascular ocular tissues .drainage of the metabolic wastes into 
the venous system and maintaining an optimum pressure in the eye, which it 
is also important to give the rigidity necessary for optical alignment of cornea, 
lens and retina (Sears, 1981).
(1.3.1) FORMATION OF AQUEOUS HUMOUR
There are three basic mechanisms by which material may cross an epithelial 
barrier: active transport, diffusion and ultrafiltration. Approximately 80% of 
aqueous secretion is produced by the non-pigmented epithelium as a result 
of an active metabolic process. This process requires the input of energy 
usually in the form of ATP (Abdel-latif, 1983). The active metabolic process 
depends on several enzymatic systems especially the NaVK^ATPase pump 
which secretes Na  ^ions into the posterior chamber. This creates an osmotic
pressure difference across the epithelial layers and water movement follows 
passively along the chemical gradient (Kanski et al, 1995). Among the ions 
that seem to be actively transported into the clefts between band in the 
epithelial cells are chloride and bicarbonate (Bill, 1975). A very clear 
evidence was found for the transport of both sodium and chloride ions in 
rabbits in vitro, but sodium transport appeared to be the most important. In 
fact it does not matter which ion is transported as long as the transport 
causes a net flow of water into the posterior chamber and consequently the 
fluid entering the posterior chamber is almost isotonic with plasma (Bill, 
1975). The remaining 20% of aqueous is produced by ultrafiltration and 
diffusion which are dependent on the level of blood pressure in the ciliary 
capillaries, the plasma oncotic pressure and the level of IOP (Kanski et al, 
1995). The effect of hydrostatic and oncotic pressure differences across the 
ciliary epithelium thus is a pressure of about 13mmHg tending to move water 
in to the process from the posterior chamber (Bill, 1975). Diffusion of solutes 
across cell membranes occurs from the side of greater concentration to the 
side of lesser concentration. Ultrafiltration occurs when the flux of a 
substance across the membrane is increased by a hydrostatic driving force. 
That transport is induced under the influence of increased hydrostatic 
pressure. Although all three processes may contribute to the formation of 
aqueous humour, it is likely that the greatest contribution comes from the 
active transport of solute ( probably Na^ ) followed by the osmotic flow of 
water into the posterior chamber (Cole, 1984). The reason for concluding 
that active secretion contributes to most of the aqueous production is that the 
concentration of electrolytes in the secreted aqueous is not equal to that of a
simple ultrafiltrate of the plasma. Also if the aqueous were simply ultrafiltrate 
of plasma, then the concentrations of positive ions such as sodium and 
potassium would be greater in the plasma than in the aqueous.
Morphological, biochemical and developmental approaches have been used 
to study the cellular mechanisms involved in the formation of aqueous 
humour. The effects of drugs commonly used in the treatment of glaucoma to 
suppress the rate of aqueous formation (for example, timolol and 
acetazolamide) have sparked additional interest in the study of the 
mechanisms of aqueous humour formation. Recent findings regarding the 
role of intracellular cyclic adenosine monophosphate (cAMP) levels in 
aqueous humour production and IOP have implicated the adenylate cyclase 
enzyme complex in the control of IOP .
Carbonic
onhydrose
HCO3- + H +
Ultrofiltrotion
PC
^ N0 +K+
ATPose
No +
Osmotic water fluxNa +
NPE
Figure1.2 Hypothetical program of aqueous production with standing gradient 
osmotic flow model. Na"^ K^"^  ATPase is located in highest concentration along 
lateral cellular interdigitations. Role of transport of Cl is still in question. NPE, 
nonpigmented epithelium, PC, posterior chamber. (Caprioli, 1984).
(1.3.2) CILIARY EPITHELIUM
The ciliary body is divided into two parts; an anterior pars plicata and a 
posterior pars plana. The pars plicata is composed of 70 radially oriented 
ciliary processes which project into the posterior chamber. The ciliary 
process consists of two layers of ciliary epithelium (Kanski et al, 1995).
The ciliary epithelium consists of two layers: the non-pigmented ciliary 
epithelium (NPE) and the pigmented epithelium (PE). The NPE lies adjacent 
to the posterior chamber and is in direct contact with the aqueous humour. 
The PE lies between the NPE and the stroma. These PE cells are cuboidal 
and contain numerous melanosomes but are relatively poor in intracellular 
organelles compared to the NPE. The NPE cells are columnar and contain 
numerous mitochondria and rough and smooth endoplasmic reticulum 
characteristic of a highly metabolically active cell. The cell membrane of the
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NPE cells has numerous basal infoldings and multiple convoluted lateral 
interdigitation. Various types of intercellular junctions join the NPE and PE 
cells; gap junctions, puncta adherentia, and tight junctions are all present. 
The NPE is thought to be the key structure responsible for aqueous humour 
formation. A number of enzyme systems have been demonstrated in this 
layer. These include nucleotide phosphatases (especialy ATPase), 
adenylate cyclase and carbonic anhydrase. The role of the PE is still 
obscure (Caprioli, 1984).
11
ù  0
RBC
Figure1.3 Schematic diagram of nonpigmented and pigmented epithelial 
cells. Note apices of cells face each other. Bl, basal infolding; BM, 
basement membrane; CC, ciliary channels; DES, desmosomes; FE, 
fenestrated capillary endothelial; GJ, gap junction; MEL, melanosome. ; MIT, 
microcondrion; RBC, red blood cell; RER, rough endoplasmic reticulum; TJ, 
tight junction. (Caprioli, 1984).
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(1.3.3) COMPOSITION OF AQUEOUS HUMOUR
The aqueous humour is composed predominantly of electrolytes and low 
molecular weight compounds with some protein (see Tablel) and there are 
significant differences from plasma in several of the components. Aqueous 
receives contributions from a variety of sources including the corneal 
endothelium, iris and lens, in addition to active secretion from the ciliary 
body. Several trace compounds are also present in aqueous humour, 
including steroid sex hormones, enzymes such as carbonic anhydrase, 
lysosomes and plasminogen activator. Low levels of catecholamines, 
prostaglandins and cyclic nucleotides are present in normal aqueous, but the 
source of these compounds is uncertain. The protein content of aqueous is 
very low (about 1/500) of plasma, and the major source is albumin (Forrester 
et al, 1996). It is not clear what happens to the proteins that passes out of 
the capillaries of the ciliary process. Part of it probably is transported with 
pinocytosis into the posterior chamber, part may be metabolized, some may 
return in to the capillaries with diffusion or pinocytosis, and some protein may 
leave the ciliary processes with a flow of the tissue fluid moving through the 
ciliary body into the supraciliary and suprachoroidal spaces (Bill, 1975).
Some substances such as glucose and urea, are present in lower 
concentration in the aqueous than in the plasma. Utilization of these 
substances by the tissues of the eye or loss of the substances in the 
posterior portion of the globe may account for the differences in 
concentration. Other substances such as ascorbic acid and hyaluronic acid 
are present at much higher levels in the aqueous and are transported by 
active secretion 5-HT has been shown to exist in aqueous humour (martin.
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1988). Chloride and bicarbonate concentrations vary among different 
species.
These differences in ionic concentrations have prevented the acceptance of a 
universal theory for the production of aqueous humour (Harold and Daniel, 
1977).
Tab le l.1 Composition of aqueous humour compared with plasma. 
Concentrations expressed in mmol/kg of water, mg/dL, meq/dL in human. 
(Forrester et al, 1996).
Component Aqueous Plasma Units
Glucose 7-3.9 5.6-6.4
Lactate 4.5 0.5-0.8 mmol /kg
Ascorbate 1.1 0.04
Albumin 5.5-6.5 3400
transferrin 1.3-1.7 mg/dL
Fibronectin 0.25 29
IgG 3.0 1270
Na 142 130-145
K 4 3.5-5.0 meq/dL
HCO3 20 24-30
Mg 1 0.7-1.1
Ca 1.2 2.0-2.6
Cl 131 92-125
(1.3.4) DRAINAGE OF AQUEOUS HUMOUR
The outflow of aqueous from the eye is regulated at several different levels, 
including the trabecular meshwork, the uveoscleral system, and, outside the 
globe the episcleral vessels.
Aqueous flows from the posterior chamber into the anterior chamber through 
the pupil and is drained by the following two different routes (Kanski, et al, 
1995).
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(A) Schlemm's canal or trabecular (conventional) route accounts for 
approximately 90% of aqueous humour outflow in humans. The aqueous 
humour is drained through the tissues at the angle between the iris and the 
corneo-scleral junction the so-called filtration angle. It diffuses through the 
trabecular meshwork into a structure known as the canal of Schlemm. The 
aqueous humour is drained from the canal of Schlemm through collecting 
channels into the venous circulation (venules which are closely associated 
with it). This is a bulk flow, pressure-sensitive route so that increasing the 
pressure head will increase outflow. Trabecular outflow can be increased by 
drugs (parasympathomimetics, sympathomimetics), laser trabeculoplasty or 
trabeculotomy (Kanski et al, 1995).
(B) The uveoscleral ( unconventional) route accounts for the remaining 
10% of aqueous outflow The aqueous flows from the iridocorneal angle ( the 
filtration angle) into the interstitial tissue spaces between the muscle bundles 
of the ciliary muscle in the ciliary body. These spaces open in turn into the 
suprachoroidal space from which fluid can pass through the venous 
circulation in the ciliary body, choroid and sclera into the episcleral tissues. 
The pressure in the suprachoroid is lower than that in the anterior chamber; 
the difference being at least a few mm of Hg under normal conditions. In the 
uveoscleral outflow, a portion of the aqueous passing into the ciliary body is 
absorbed into the uveal blood vessels. Contraction of the ciliary muscle by 
parasympathomimetic drugs such as pilocarpine opens large spaces in the 
trabecular meshwork and increases the drainage through Schlemm's canal 
At the same time the uveoscleral drainage is almost stopped due to 
compression of the interstitial spaces within the ciliary muscle (Kanski et al.
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1995). Atropine produces relaxation of the ciliary muscle which reduces the 
drainage through Schlemm's canal because of tight packing of the trabecular 
meshwork pores. On the other hand, the uveoscleral drainage increases due 
to increasing the spaces between the muscle bundles (Bill, 1969). The 
uveoscleral outflow drains some 0.2 to 0.5pl of aqueous/min at a steady rate 
not affected by lOP. The trabecular outflow carries the greater portion of 
aqueous from the eye in man, approximately 1.8 to2.5pl /min in man (Bill and 
Maepea, 1989).
Sclera Scleral spur
Ciliary
muscle
Sclera Scleral spur
Figure1.4 Diagrams to illustrate the effects of pilocarpine-induced contraction 
of the ciliary muscle on the scleral spur and the trabecular tissues. A, 
untreated; B, treated (Davson, 1990).
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Figure1.5 A: ciliary muscle is relaxed, spaces between lamellae of uveal and 
coneoscleral meshwork are narrow, and interstitial spaces between muscle 
bundles of ciliary muscle are wide. Aqueous humour leaves the anterior 
chamber by routes via Shlemm canal and by routes via interstitial spaces of 
ciliary muscle. B; ciliary muscle is contracted, spaces in different parts of 
meshwork are relatively wide, and interstitial spaces between muscle bundles 
have almost disappeared Aqueous humour leaves the eye almost entirely by 
routes via Shlemm canal (Davson, 1990).
(1.4 ) C yclic  AMP
Cyclic 3,'5-adenosine monophosphate (cAMP) is an intracellular second 
messenger. The role of cAMP was revealed by the work of Sutherland and 
his colleagues in the late 1950s. This discovery demolished at a stroke the 
barriers that existed between biochemistry and pharmacology, to the great 
benefit of both disciplines (Rang, Dale and Ritter 1995).
CAMP is a nucleotide synthesized within the cell from ATP catalyzed by the 
action of adenylate cyclase. It is produced continually and inactivated by 
hydrolysis to 5-AMP, by the action of a family of enzymes known as 
phosphodiesterases
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CAMP has become especially important in pharmacology for several reasons. 
Firstly, because it led to the discovery of adenylate cyclase.
Secondly, because the stimulation of adenylate cyclase by hormones was the 
first receptor-mediated event that could be studied in a cell-free system. 
Moreover, continued study of this phenomenon has led to much of our 
understanding of what receptors are and how they act. Furthermore cAMP is 
important physiologically and clinically.
A large variety of drugs, hormones and neurotransmitters produce at least 
some of their effects by altering the intracellular level of cAMP by either 
stimulating or inhibiting the catalytic activity of adenylate cyclase, thereby 
leading to either an increase or a decrease in the level of cAMP 
intracellularly. (Robinson, 1983).
The regulatory effects of cAMP on cellular function are many and varied, 
including , for example, enzymes involved in cell metabolism, cell division 
and differentiation, ion transport and ion channel function, leading to changes 
in neuronal excitability. These varied effects are all brought about by a 
common mechanism, namely the activation of various protein kinases by 
cAMP.
(1,5) GLAUCOMA
The glaucomas are a group of potentially blinding ocular conditions. 
Because the pathophysiology, clinical presentation and treatment of the 
different types of glaucoma are so varied, there is no single definition that 
adequately encompasses all forms. Understanding this concept helps to 
explain, for example, why one patient with glaucoma' may have no symptoms 
whilst another experiences sudden pain and redness (Kanski et al, 1995).
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The two main types of glaucoma are congenital (developmental) and 
acquired. Further subclassification into open-angle and angle-closure types 
is based on the mechanism by which aqueous outflow is impaired. The 
glaucoma may also be primary or secondary depending on the presence or 
absence of associated factors contributing to the pressure rise (Crick, 1978). 
In primary glaucoma's the elevation of lOP is not associated with any other 
ocular disorder whereas in secondary a recognisable ocular or non-ocular 
disorder alters aqueous outflow which, in turn, results in elevation of lOP 
(Henson, 1993).
(1.5.1)Primarv open-angle glaucoma (POAG)
POAG, is generally bilateral, characterized by the following
•Adult onset
•An IOP>21mmHg at some point in the course of the disease 
•Glaucomatous optic nerve head damage 
•An open angle of normal apperance 
•Visual field loss (Kanski et ai, 1995).
Despite this definition it should be emphasized that approximately 16% of all 
patients with otherwise characteristic POAG will have lOP 
consistently<22mmHg and constitute a sub-group referred to as normal- 
tension glaucoma’.
POAG is the most prevalent of all glaucomas, affecting approximately 1 in 
100 of the general population over the age of 40 years. The condition affects 
both sexes equally and is more severe in blacks than in whites. Age is one of 
the main risk factors in POAG. It is unusual for the diagnosis to be before the 
age of 40 years. Glaucoma can also affect younger people, and
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measurement of eye pressure is an important of a routine eye examination 
(Pavan, 1991).
Elevation of lOP in patients with POAG is caused by increased resistance to 
aqueous outflow in the drainage channels. The development of visual field 
loss is related to progressive loss of axons in the optic nerve head. Several 
mechanisms have been postulated to be responsible for this damage, but no 
single mechanism can adequately explain the great variation in susceptibility 
to damage and the pattern of damage seen. Patients with POAG are usually 
asymptomatic until a significant loss of visual field has occurred (Kanski et 
al, 1995).
(1.5.2) Primary angle- closure glaucoma (PACG)
PACG is the condition in which elevation of lOP occurs as a result of
obstruction of aqueous outflow by partial or complete closure of the angle by 
the peripheral iris. It is more common in females by a ratio of 4:1 (Janski, 
1992). Unlike POAG the diagnosis depends to a great extent on examination 
of the anterior segment and careful gonioscopy. The presence of a normal 
optic nerve head and absence of visual field loss does not preclude the 
diagnosis of PACG. The disease occurs in anatomically predisposed eyes 
and is frequently bilateral, although presentation of the acute form is 
frequently asymmetrical. Age and family history are among the risk factors in 
PACG. The average age at presentation is about 60 years and the 
prevalence increases thereafter (Kanski et al, 1995).
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(1.6) PHARMACOLOGY OF INTRAOCULAR 
PRESSURE
Parasympathomimetic drugs (those that cause the pupil to constrict) 
generally result in a lowered lOP. In addition to producing contraction of the 
iris sphincter muscle, these drugs also stimulate contraction of the ciliary 
muscle. The trabecular meshwork, being attached to the scleral spur, is in 
effect a tendon of origin for the ciliary muscle, traction on which will result in a 
significant change in the geometry of the trabecular meshwork. These drugs 
reduce uveoscleral outflow facility and produce a simultaneous increase in 
trabecular outflow facility. Since trabecular facility is approximately an order 
of magnitude greater than uveoscleral facility, the net effect is a marked 
elevation in the outflow facility with a concomitant decrease in lOP. This 
effect is particularly magnified in eyes that have abnormally high lOP 
(abnormally low outflow facility). The parasympathomimetics, include direct 
parasympathomimetic agonist drugs ( which act directly on the ciliary muscle) 
such as pilocarpine and carbachol and indirect agonists ( the choline 
esterase inhibitors) such as physostigmine (Voulghan and Asbury, 1983). 
Pilocarpine is widely used in glaucoma. Cholinesterase inhibitors are no 
longer used due to adverse effects on the eye.
Topically applied epinephrine (1% to 2%) is a valuable drug in the treatment 
of glaucoma. The drug increases the outflow through both routes of drainage 
(the trabecular meshwork and uveoscleral routes ) and decreases the rate of 
production of aqueous humour, but its effect on the outflow is more 
predominant and long lasting. The decrease in production of aqueous 
humour is probably caused by stimulation of receptors in the ciliary
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processes, but the reason for increasing outflow is still unclear (Moses, 
1981).
Timolol is very widely used to treat glaucoma. Its mechanism of action has 
been controversial for many years; some evidence suggests that it acts 
through p-blockade while other results suggest a different mechanism.
Timolol is an antagonist at the p-adrenoceptor, but for a compound to be 
active as a pharmacological antagonist, there must tonic agonist-induced 
stimulation to block. Thus, the ability of timolol to reduce aqueous formation 
and lOP implies that endogenous adrenergic tone stimulating p- 
adrenoceptors exists in the eye.
The p-agonist isoprenaline stimulates cAMP synthesis and increases 
aqueous humour formation and lOP (Nathanson, 1981a). Timolol as a 
potent non-selective p-adrenoceptor antagonist (Scriabine et al., 1973) 
blocks this effect and decreases aqueous secretion in the monkey eye 
suggesting the effect is mediated by p-adrenoceptors (MiichI and Nagataki, 
1983).
The p2-agonist, terbutaline, increases aqueous humour formation by about 
100% in cynomolgus monkey and this effect was completely abolished by 
timolol (Nilsson et al., 1990).
It has been observed that the rate of aqueous humour flow in humans 
undergoes a circadian rhythm characterized by a higher flow during working 
hours (highest being in the morning) and lower flow during sleep (Reiss et 
al., 1984). In contrast to day time, 0.5% timolol is devoid of any ocular 
hypotensive effect during sleep (Topper and Brubaker, 1985). In contrast
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with the above, some data suggest that conventional p-adrenoceptors are not 
involved.
Topically applied timolol can block p-adrenoceptors in the eye as evidenced 
by the attenuation of the ability of topical isoprenaline to increase the 
production of cAMP in the aqueous humour of the rabbit (Vareilles et al, 
1977; Schmitt et al., 1981b). However the dose of timolol required to block 
this response to isoprenaline is very much less than that required for ocular 
hypotensive activity, thus implying that different mechanisms are involved in 
both phenomena. This is supported by the observation that the effectiveness 
of various p-antagonists in lowering lOP in rabbit models of ocular 
hypertension did not correlate with their ability to block p-adrenoceptors 
(Bonomi et al., 1979). In the bovine perfused eye, it was concluded that 
there was little correlation between aqueous formation rate and the ciliary 
epithelial content of cyclic AMP (Shahldullah, Wilson and Millar, 1995). 
Thus the direct correlation between aqueous humour formation and ciliary 
cAMP production which many authors assume, is subject to considerable 
uncertainty.
It is possible that timolol reduces lOP by acting on more than one 
mechanism.
What might be the signalling action of cAMP in the ciliary epithelium to 
regulate flow?
One among several articles (Crook et al, 1993) implicating the activation of 
the cAMP pathway of the ciliary epithelium as regulatory for ion transport and 
aqueous production, proposes the upregulation of Na^/ KV Cl" cotransport by 
protein kinase A and downregulation by protein kinase 0. This work was
done in human fetal non-pigmented ciliary epithelium in short term culture. In
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permeabilized rabbit ciliary epithelium, Na  ^ K^-ATPase is reported to be 
inhibited by activation of protein kinase A (Delamere and King, 1992). Other 
in vitro findings (Delamere and King, 1990) appear to conflict with some in 
vivo research showing either increases or decreases of aqueous formation 
with accelerated cAMP production (which is increased by beta-adrenergic 
agonists and decreased by az agonists or p-adrenergic blocking agents). 
Therefore aqueous formation in the eye is affected by the activation and the 
inhibition of several receptor subtypes. Further studies of other receptor 
interactions are required for better comprehension of the system (Horio, 
Sears, Mead, Matsui and Bausher, 1996).
Acetazolamide is a potent inhibitor of carbonic anhydrase enzyme, which 
catalyzes the reaction of H2O + CO2 to yield HCO3 + Systemic treatment 
with acetazolamide and other carbonic anhydrase inhibitors decreases lOP 
by reducing aqueous formation. There is a substantial evidence that 
acetazolamide directly affects the transport mechanisms of the ciliary 
epithelia. Inhibition of carbonic anhydrase lowers the aqueous Cl 
concentration in primates and the HCO3" in rabbits. Acetazolamide 
decreases the rate of Na"^  and HCO3 transport into the posterior chamber, 
suggesting a linkage of the accession of these two solutes into the posterior 
chamber. Knowledge of the mechanism by which carbonic anhydrase activity 
is coupled to Na"^  and HCO3" movement into the posterior chamber is still 
sought. Acetazolamide was the first such agent to be used in the treatment 
of glaucoma, but topically active carbonic anhydrase inhibitors, such as 
dorzolamide, are now available (Hart, 1992).
lOP may rapidly be lowered by increasing blood osmolarity; this may be
accomplished by intravenous infusion of urea or mannitol or by oral ingestion
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of glycerin. These agents are valuable in the treatment of acute angle 
closure glaucoma. Water loading, on the other hand lowers blood osmolarity 
so water will be drawn into the eye. If the facility of outflow is good, there will 
be little change of lOP , but if facility of outflow is reduced, ingestion of a 
quart of water may raise lOP by 8mmHg or more (Moses, 1981).
(1.7) OPTIC NERVE
The optic nerve is surrounded by the optic stalk through which arteries and 
veins enter the eye. The optic nerve is not a true nerve like peripheral nerve, 
but is actually a nerve fibre tract whose fibres are derived from the ganglion 
cells of the retina. It is composed of the axons and myelinated sheaths. 
Optic nerve fibres like all other nerves, degenerate if the connections with 
their nerve cell bodies are severed. The optic nerve is severely damaged 
under high lOP, but when this pressure is reduced so the damage to optic 
nerve ceases
(1.8) BLOOD SUPPLY TO THE EYE
98% of the blood to the eye passes through the uveal tract, of which 85% is 
through the choroid (Forrester et al, 1996). The blood supply to the eyeball 
is derived from the ophthalmic artery; which is derived from a branch of the 
internal carotid artery. This ophthalmic artery divides into 10-20 branches of 
ciliary arteries, two of them are long posterior ciliary arteries which run 
forward through the choroid to the ciliary body where they anastomose with 
the anterior ciliary arteries to form what has been incorrectly called the major 
circle of the iris (f ig 1.6 )., incorrectly, because the circle is actually in the 
ciliary body. From this circle, arteries run forward to supply the ciliary and iris
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blood vessels and backward to supply the choroidal circulation. Venous 
blood from the uvea drains into the episcleral veins and from there into the 
four vortex veins, finally leaving the eye by way of the inferior and superior 
ophthalmic veins. The remaining blood entering the eyeball is carried by the 
central retinal artery (Forrester et al, 1996). This central retinal artery enters 
the eye through the optic nerve and divides into four main branches running 
within the retina to supply the inner retina (fig 1.6 ). The venous blood from 
the retina drains into the retinal veins and then into the ophthalmic veins. The 
outer retina has a lack of blood vessels, it derives its nutrient supply from the 
choriocapillaries (Bill, 1981).
Canal of Schlemm 
Limbal network
Major arterial circle of iris 
Iris vessels
Short posterior ciliary arteries
Choriocapillans
Retinol vessels
Conjunctival vessels 
in te rio r ciliary vessels
Episcleral vessels 
Vortex vein
posterior ciliary artery 
^ o r t  posterior ciliary arteries
Durai vessels 
iol vessels 
Central retinal artery and vein
Figurel.6 Blood vessels of human eye. (Modified from Leber, 1903)
26
(1.9) BLOOD-AQUEOUS BARRIER
The blood-aqueous barrier means certain substances encounter difficulty in 
entering the ocular tissues. This barrier has two parts: the epithelial part is 
represented by the tight junctions between the non-pigmented cells of the 
ciliary epithelium in the ciliary body (Davson, 1956 ). The other part of the 
blood-aqueous barrier is the endothelial part, and is constituted by the non­
fenestrated cells of the iris capillaries. The two parts of the barrier work 
together to exclude large molecular-weight substances such as proteins.
They are effective with respect to the low molecular-weight substances such 
as sucrose and fluorescein due to the presence of a semi- porous membrane 
with a pore radius of about 10.4nm. This barrier excludes the proteins of the 
clotting cascade and maintains the clarity of the aqueous and the optical 
integrity of the eye. ( Vegge, 1971; Uusitalo, Palkama & Stjernschantz, 
1973 ).
(1.10) BREAKDOWN OF BLOOD- AQUEOUS BARRIER
Under certain experimental and pathological conditions such as trauma, 
injury or paracentesis (removal of aqueous humour from the anterior 
chamber), the blood- aqueous barrier breaks down (Berman, 1991), so that 
large molecular-weight substances such as proteins that are normally and 
almost completely excluded from penetration now appear in the aqueous 
humour in large amounts. The aqueous humour becomes cloudy (seen as 
flare in the slit-lamp microscope) due to leakage of plasma proteins into the 
posterior and anterior chambers. It may even become plasmoid owing to the
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presence of fibrin and other proteins. Inflammatory cells are also likely to be 
present when the blood-aqueous barrier breaks down (Forrester et al,
1996). The breakdown of this barrier is usually but not always accompanied 
by a rise in lOP which may be spectacular i.e.up to 60-80mmHg (Davson, 
1990). The vascular engorgement within the eye suggests that the prime 
action is on the blood vessels. A typical agent is the hydrochloride of 
nitrogen mustard. When this is applied topically to the eye the lOP rises 
rapidly (Davson and Quilliam, 1947; Davson and Huber, 1950). Wessely 
(1900) showed that the breakdown could be reduced by sympathetic 
stimulation or treatment of the eye with epinephrine, and Cole (1961) showed 
that the anti-inflammatory agent, polyphloretin, also prevents the breakdown 
of the blood aqueous barrier.
(1.11) ADENOSINE
Adenosine produces many physiological and pharmacological effects both in 
the periphery and in the central nervous system. There is evidence that it 
functions as a mediator in the central nervous system (Phillis and Wu 1981, 
Stone 1991a).
(1.11.1) Adenosine receptor agonists and actions
The effects of adenosine are mediated by two distinct receptors, Ai and A2,
linked respectively, to the inhibition and stimulation of adenylate cyclase, 
thus reducing or increasing intracellular cAMP formation (Stone 1991b, 
Collis & Hourani 1993). The main effects of adenosine and its agonists are
(1) vasodilatation, including coronary blood vessels (A2), except for the 
kidney, where Ai receptors produce vasoconstriction. Adenosine infusion 
causes a fall in blood pressure. (2) Inhibition of platelet aggregation (A2). (3)
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Bradycardia, block of atrioventricular conduction (Ai), and reduction of force 
of contraction of the heart. (4) Bronchoconstriction (Ai) (Rang etal 1995).
(1.12) Adenosine T riphosphate (ATP)
Adenosine and adenosine triphosphate (ATP) are components of all cells, 
both are released from cells into the extracellular medium, and both have 
marked effects on peripheral tissues and the central nervous system. ATP is 
stored together with acetylcholine or noradrenaline in their respective 
synaptic terminals as a co-transmitter (Stone, 1995).
In the extracellular space, ATP is rapidly metabolized to adenosine by 
ATPase and nucleotidase enzymes. The effects of ATP are usually exerted 
in the postsynaptic cell, producing contraction or relaxation of smooth 
muscles. ATP also potentiates the effects of noradrenaline on some tissues 
(Stone, 1995).
ATP is one of the NANC (non-adrenergic non-cholinergic) transmitters which 
function as neurotransmitters at many peripheral effector junctions and also 
as a fast transmitter in the central nervous system. It also functions as an 
intracellular mediator, inhibiting the opening of membrane potassium 
channels.
ATP acts on several types of purinoceptors (P2) They are distinguished on 
the basis of their agonist selectivity. One of these (P2x) is a ligand-gated ion 
channel. Others, P2Y P2Z and P2U are all coupled to various second 
messengers.. Drugs acting selectively on ATP and ADP receptors have not 
yet been developed for clinical purposes ( Burnstock 1981, 1985, 1988, 
Evans et al. 1993).
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Burnstock and his colleagues have shown that ATP is released, in a calcium- 
dependent fashion, on nerve stimulation.
The fast transmitter function of ATP, including its vasoconstrictor function, is 
mediated by P2x-receptors, which are blocked by suramin and a purine 
analogue, ANAAPP3 (Burnstock, 1988). The use of these blocking agents 
has helped to clarify the physiological role of ATP. Its other actions are 
linked to various second messenger systems, for which no specific 
antagonists are known.
In most cells, intracellular Ca^* is contained mainly in the endoplasmic 
reticulum and in mitochondria. Many agents that contract smooth muscle do 
so by activating membrane-bound phospholipase C, thereby causing the 
intracellular formation of inositol tris-phosphate which causes Ca^  ^ to be 
released from the endoplasmic reticulum (Berridge, 1993). This is the 
mechanism of ATP when it activates the Pzu receptor. This can occur without 
any movement of Ca^  ^ across the plasma membrane (Shahldullah et al, 
1995).
Secretory cells are also in general activated by an increase in intracellular 
Ca^  ^ and some secretory cells also have P2u receptors (Dubyak and EL- 
Moatassim, 1993). The presence of these receptors has recently been 
confirmed in ciliary epithelial cells (Shahldullah and Wilson, 1997) where 
again they cause liberation of intracellular Ca^ "^ . Since ATP can cause such a 
fundamental change in function of ciliary epithelial cells, it would be of 
interest to know whether exogenous ATP can alter aqueous humour 
formation and hence, perhaps, lOP.
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(1.13) 5-Hydroxytryptamine (5-HT)
5-HT (5-hydroxytryptamine) was originally discovered in 1948 when the 
identity of a vasoconstrictor substance release from blood platelets was 
elucidated. It was originally called serotonin, a name that is still widely used. 
It was shown to have an important role as a neurotransmitter, as well as a 
local hormone in the central and peripheral vascular system, which is 
involved in the regulation of a variety of physiological functions and 
behaviours. In addition, 5-HT has been implicated in the pathophysiology of 
different neuropsychiatrie disorders, such as anxiety, depression, 
schizophrenia, eating disorders and migraine (Pasqualetti et al, 1996). It 
comes from many sources other than blood, and has many effects in addition 
to causing vasoconstriction. 5-HT is present in the diet but most is 
metabolized before entering the blood. It originates from the precursor amino 
acid, tryptophan. Tryptophan is converted to 5-hydroxytryptophan in 
chromaffin cells and neurons by tryptophan hydroxylase enzyme. The 5- 
hydroxytryptophan is then decarboxylated to 5-hydroxytryptamine by the 
action of a decarboxylase enzyme. It is degraded by the action of mono 
amine oxidase enzyme to 5-hydroxy indole acetic acid (Rang et al, 1995).
(1.13.1) Pharmacological effects of 5~HT
(1) In the gastrointestinal tract it increases motility.
(2) On blood vessels (i) Constriction of some arteries and veins, mediated 
by 5 -HT2A receptors.
(ii) vasodilatation by several mechanisms, all operating through 5-HTia 
receptors.
31
(3) On platelets 5-HT causes platelet aggregation.
(4) On CNS : excites some neurons and inhibits others, but the normal 
effects are predominantly inhibitory. Four major classes of serotonin 
receptors termed 5HTi, 5 HT2 , 5HTa and 5 HT4 have been characterized 
(Frazer, Maayani and Walfe, 1990). The 5HTi group can be further 
subdivided into 5HT ia, 5HT ib, and 5 HT id subtypes. They are 
differentiated by the kinetics of agonist and antagonist binding to the 
receptor, and by their regional distribution within the central nervous 
system (Forrester et al, 1996).
The 5 -HT1A subtype shows a high affinity for agonists such as 8-OH-DPAT 
and 5-CT (Middlemiss and Fozard, 1983) and is positively or negatively 
linked to the adenylate cyclase-cAMP cascade (Frazer et al., 1990).
These receptors are widely distributed throughout the central nervous system 
and some of the drugs which act on them have striking behavioural effects ( 
Stone, 1995). The 5-HTia agonist 8-OH-DPAT facilitates male rat sexual 
behavior and produce an anxiolytic action in animals, but the role for 5-HTia 
binding sites is still in question. 8-OH-DPAT also produces a pronounced 
hypotensive effect in animals: this effect may be 5-HTiA-mediated. In 
general, 5-HTia agonists produce a hypothermic response in rodents. The 
hypothermic effect of 8-OH-DPAT is due to its agonist action at presynaptic 
5-HT receptors. 8-OH-DPAT also serves as a training drug in tests of 
discriminative stimulus control of behavior in cats (Glennon, 1987). 
5-Carboxamidotryptamine (5-CT) is an agonist that acts on 5HTi-like 
receptors (5-HT ia, 5-HT ib, 5HT id). It also causes elevation of cAMP by
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interaction with a specific 5-HT receptor which is 5-HTi-like (Trevethick et al, 
1986).
(1.13.2) Pharmacological effects of 5-CT
(I) On CNS: It produces neuronal inhibition and behavioral effects (sleep, 
feeding, anxiety) mediated through 5-HTi receptors (5-HT ia, 5HT ib, 5HT id) 
and presynaptic inhibition produced via 5-HT id receptor
(ii) On blood vessels: 5-CT produces a consistent, dose-related decrease in 
arterial (diastolic) blood pressure and carotid artery vascular resistance, due 
to its action on 5-HTi-like receptors mediating relaxation of vascular smooth 
muscle( Feniuk et al., 1981; 1984). Vasodilatation was observed in several 
tissues, but the skin, ears and stomach responded most prominently (Saxena 
et al, 1985).
(iii) On the heart: 5-CT causes a dose-related tachycardia and is 
approximately fifty times more potent than 5-HT in this aspect (Connor et al, 
1986).
Antagonists that block the effect of 5-CT on its receptors are spiperone 
(selective on 5-HT ia receptors) methiothepin and ergotamine (on 5-HT ia, 5- 
HTib, 5-HT id) (Zifa and Filllon, 1992).
In 1981, Moro and co-workers found that intravitreal injection of 5,6- 
dihydroxtryptamine, a serotonergic neurotoxin, causes miosis implicating 5- 
HT in the control of pupil size. This has been substantiated by the finding 
that pupil size is also decreased by the intravenous injection of ketanserin, a 
specific 5 -HT2 receptor antagonist (Krootila, Uusitalo and Palkama, 1987). 
The presence of serotonergic neurones in the iris-ciliary body has been
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described by Tobin, Unger and Osborne (1988) and functional attributes of 
the amine have been demonstrated by other studies.
There is now considerable evidence that serotonin is a transmitter in the 
retina (Osborne and Barnett, 1990), but information on its role in the front of 
the eye is much less abundant. In the eye, the identification of 5-HT 
receptors, in human, is of particular importance in view of the known 
relationship between cAMP and the regulation of lOP (Sears et al., 1984; 
Bartels et al., 1987). Recent studies by Martin et al. (1992) showed that 
there is a correlation between the content of serotonin in the aqueous fluid 
and lOP in the human eye.
Previous workers suggest that the actual existence of endogenous serotonin 
neurons in either the trabecular region or the iris-ciliary body has not been 
demonstrated. However, when iris-ciliary body tissues are incubated in vitro 
with exogenous 5-HT, the amine can be shown to be taken up and localized 
in neurons by use of immunohistochemistry. It is also well known that 
immunohistochemical procedures have failed to localize endogenous 
serotonin in the mammalian retina, but when the retina is exposed to 
exogenous amine, it can be localized to certain amacrine cells (Meyer- 
Bothling et al, 1993).
It has been found that an intraocular injection of 5HT into rabbit anterior 
chamber causes an increase in both lOP and protein concentration in the 
aqueous (Chidlow et al, 1995).
5-HT ia receptors exist in the rabbit iris-ciliary body (Mallorga and Sugrue, 
1987 ;Tobin and Osborne, 1988). Therefore the effect of 5-HT on lOP in 
rabbits may be due to action on 5-HTia receptors. 5-HTib receptors can be 
distinguished from 5-HTia subtype by their lower affinity for spiperone and
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lack of affinity for 8-OH-DPAT. They are found exclusively in rodents, are 
negatively linked to adenylate cyclase and are antagonized by propranolol 
(Middlemiss and Hutson, 1990). The 5-HTic subtype(now reclassified as 5- 
HT2 , which is found in high density in choroid plexus, is coupled to the 
hydrolysis of inositol phosphates (Conn et al., 1986). A 5-HTid receptor 
subtype has been characterized in bovine, pig, guinea pig, pigeon and 
human brain membranes but no reports indicate location in the eye. These 
sites display high affinity for 5-HT and related tryptamines but relatively low 
affinity for 8-OH-DPAT (Peroutka, 1991). These receptors are also 
negatively linked to cAMP production but can be distinguished from 5-HTib by 
their lower affinity for propranolol (Hoyer et al., 1990; Shoeffter et al., 1988). 
Three mechanisms can be envisaged by which 5-HT might alter lOP ; action 
on outflow resistance, on the uveoscleral pathway and action on aqueous 
secretion. The action of serotonin in increasing lOP by any of these 
mechanisms can only be determined by experiment.
It has been found that topically applied ketanserin lowered lOP in rabbits, 
cats and monkeys (Chang, Burke and Potter, 1985; Conway and Lewis, 
(1989). The 5 HT2A antagonist, ketanserin has been evaluated on lOP in 
certain patients with ocular hypertension. It is also reported that orally 
administered ketanserin also significantly reduced lOP in glaucomatous 
patients (Costagliola et al., 1989; 1990, 1991). Both Chang and co­
workers (1985) and Conway and Lewis (1989) suggest that ketanserin 
exerts its effect by suppressing aqueous humour formation and increasing 
outflow. Whether the marked increase in total outflow is due to increased 
trabecular outflow or increased uveoscleral drainage, or both, remains an 
open question. All these findings indicate that ketanserin could represent a
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new anti-glaucoma drug. There is therefore potential for further work to 
analyze the mechanisms of these effects of 5-HT agonists and antagonists on 
aqueous humour dynamics( Costagliola et al, 1991).
A great need exists for a model in which aqueous humour dynamics and their 
pharmacological manipulation can be studied. In vivo work involves the 
influence of the central nervous system and hormonal and vascular systems, 
which often complicate the interpretation of results. Additionally, there is 
increasing widespread concern about the use of animals in experimental 
science ( Fox, 1984). The benefits of its size and ready availability led us to 
investigate the bovine perfused eye further. We find that this preparation 
lends itself to the direct correlation of drug effects on lOP, aqueous humour 
formation, the uveal vasculature and the patency of the blood-aqueous 
barrier (Wilson, Shahldullah and Millar, 1993). The preparation permits 
also experimental manipulation of perfusion media and rapid sampling of the 
ocular tissues for biochemical analysis.
This is a good method for examining the action of drugs on lOP and aqueous 
humour formation and drainage.
(1.14) AIM OF PROJECT
A general aim of this project was to develop and improve the in vitro bovine 
perfused eye; also to show whether it is useful for experimental work since 
this model avoids the sacrificing of animals for research purposes. And its 
large size makes it straightforward to set up experimentally compared with 
eyes taken from other species.
An ultimate aim of such work is the development of safer and more effective 
drugs for the treatment of glaucoma.
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It was proposed to study the effects of drugs related to adenosine and to 5- 
HT on lOP in the bovine perfused eye and to try to elucidate the mechanisms 
by which these drugs may alter lOP. A further intention was to ascertain the 
effect of various ocular hypotensive drugs that have been investigated and 
analyzed by other workers either to confirm or oppose their proposals and to 
see how the use of different species, techniques and routes of administration 
might alter the effect of these drugs upon lOP.
Drugs effective by the intra-arterial route are not most likely to influence lOP 
via an alteration in aqueous formation in the ciliary body, whereas drugs 
altering lOP by the intracameral route are more likely to do so by an effect on 
outflow. In seeking to further understand the mechanism of action of these 
drugs, a biochemical technique was employed.
We used an enzyme-immuno assay technique for measuring the rate of 
cAMP formation in the ciliary processes and trabecular meshwork of the 
bovine eye, in an attempt to find a correlation between the effects of these 
drugs on lOP and on cAMP synthesis in these tissues.
Since it is generally believed that these drugs probably mediate their effects 
through changes in tissue cAMP synthesis, we may be able to identify the 
presence of the relevant receptors by measuring changes in tissue cAMP 
synthesis in response to these drugs. This may provide good evidence of the 
site of action of these drugs on lOP.
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MATERIALS AND METHODS
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(2.1) IN VITRO METHOD FOR STUDYING 
INTRAOCULAR PRESSURE
Bovine eyes obtained from the abattoir were kept at ambient temperature and 
transported to the lab. Eyes were not placed on ice since the resulting 
solidity of the fatty tissues may hamper dissection and cannulation (Wilson, 
Shahlduilah and Millar, 1993).
Within one hour of slaughter, one of the long posterior ciliary arteries was 
cleared of connective tissues and cannulated proximal to the heavily 
pigmented area which appears in the anterior wall before it enters the sclera. 
Care was taken not to damage the blood vessels running over the anterior 
surface of the globe; for this reason a few mm of each extraocular muscle 
were left attached to the globe. As shown in figure 2.1, the eye was placed in 
a jacketed holder maintained at 37°C and covered with a plastic cup to keep 
it warm and to prevent drying. The long posterior ciliary artery was perfused 
with Krebs’ solution containing :(mM) NaCI, 118; KOI, 4.7; glucose, 11.5; 
NaHCOa, 25; MgS0 4 .7H20, 1.2; KH2 PO4 , 1.2; Ascorbic acid, 0.05 and CaCb, 
2.5. The pH of this solution was adjusted to 7.4 by bubbling with O2 
containing 5% CO2 .
The experiments in the present study were conducted using a peristaltic 
pump to induce flow through the vasculature, during which time intravascular 
pressure was monitored via a pressure transducer (Isotec) and pen recorder 
(Linseis). The flow rate was commenced at 0.2ml.min  ^and increased in 5-10 
increments to 2.25ml.min )^. The four vortex veins were cut in order to allow 
flow of Krebs and successful perfusion was signalled by the appearance of 
small amounts of blood from the ends of the vortex veins. It was necessary to 
cut away some of the extraocular muscles to encourage visible flow. During
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this process (25-40min), perfusion pressure often fluctuated, usually due to 
poor alignment of the cannula with the artery, but was not allowed to exceed 
lOOmmHg. After approximately 50 minutes, when aqueous humour secretion 
had started (which was indicated by a firm globe), the anterior chamber was 
cannulated with a 23G needle connected via a rubber silicon tube to another 
needle that was connected to a water manometer. Observations of lOP from 
the water manometer were made at 5 minutes intervals.
ManometeriPump Krebs
^ohition.
Heating coil
Insulated cover
Drug A  
injeobon
Pressure
transducer
Long posterior 
cüiaiy artery
Vortex veins
Pen Recorder
Warming jacket
Figure 2.1 The bovine isolated eye, showing perfusion of the uveal 
vasculature through one long posterior ciliary artery under condition of 
constant flow rate. Perfusion pressure and lOP were both monitored as 
shown (Wilson and Shahidullah and Millar, 1993).
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Once the eyes reached a stable lOP within the range of 95 to 165mm.H2G (7- 
12mmHg) and a stable arterial pressure not exceeding lOOmmHg (and 
usually much lower than this), a drug solution or vehicle control was injected 
as a bolus dose, proximal to the arterial cannula, and the effect upon both 
lOP and arterial perfusion pressure were measured and recorded as 
described by Wilson et al, 1993. Alternatively, drugs were administered by 
arterial perfusion (Art.per) or intracameral (I.C) injection. Art.per : the drug 
was added to the Krebs solution reservoir and after mixing, the drug reached 
the posterior ciliary artery after a delay of about 10 minutes as it moved 
through the tube between the reservoir and the eye. I.C injection:- 30-60 min 
after the stabilisation of lOP another 23G needle was inserted into the 
anterior chamber. This needle was already connected via a silicon rubber 
tube to a micro syringe, the whole assembly having been prefilled with the 
drug solution or vehicle control to be injected . When lOP again had 
stabilised, the drug or control solution in a volume of 2-1 OpL was injected into 
the anterior chamber and observations of lOP and perfusion pressure 
continued.
The data collected for a period of 90 minutes were analysed by calculating 
the regression lines for lOP versus time using a Minitab, and this yields 
values for the slopes of these lines. This way of expressing the change in 
lOP allows better statistical analysis than direct comparison of lOP before 
and after drug injection. Mean values and SEM of these slopes for control 
and test eyes were then compared by the Minitab statistical package and the 
statistical significance of differences between mean values were calculated 
using AN OVA and Student’s t-test.
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(2.2) IN VITRO STUDY OF DRUG EFFECTS ON CAMP 
FORMATION.
(2.2.1) Preparation of tissues
Bovine eye ciliary processes (CP) were exposed after dissecting the eye from 
the posterior pole, and removing the vitreous, lens and anterior lens capsule 
The remaining anterior segment was everted on a ball of plasticine 
(precooled to and was then frozen by keeping at -70°C for 15-20
minutes. The frozen CP were then rapidly scraped from the eye by means of 
a sharp-edge spatula.
In order to harvest trabecular meshwork (TM) tissue, the eye was dissected 
as above then the ciliary body was gripped with forceps and torn free from 
the sclera.
This exposed the TM as a dense band of white tissue having a pigmented 
anterior edge, when it was stripped off by scraping with a small sharp spatula. 
Sometimes the TM was covered by a spongy layer of ciliary tissue which was 
easily removed to reveal the denser TM below. The identity of these tissues 
were confirmed histologically by Professor W Lee of the Department of 
Pathology, Western Infirmary , Glasgow.
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(2.2.2) Assay procedure
Assay of adenylate cyclase activity was carried out by measuring the cAMP 
present in the incubation mixtures which resulted from the above incubation 
procedure.
The cAMP assay was done using an EIA Kit supplied by the Alexis 
Corporation (Nothingham, UK) and employing a 96-well plate.
This assay is based on the competition between free cAMP and a cAMP 
tracer (cAMP linked to an acetylcholinesterase molecule) for a limited number 
of cAMP-specific rabbit antiserum binding sites. The concentration of the 
cAMP tracer is held constant while the concentration of free cAMP (standard 
or sample) varies, thus, the amount of cAMP tracer that is able to bind to the 
rabbit antiserum will be inversely proportional to the concentration of free 
cAMP in the well. This rabbit antiserum-cAMP (either free or tracer) complex 
binds to the mouse monoclonal anti-rabbit antibody that has been previously 
attached to the well. The plate is washed to remove any unbound reagents 
and then Ellman’s reagent (which contains the substrate to 
acetylcholinesterase) is added to the well. The product of this enzymatic 
reaction has a distinct yellow colour and absorbs strongly at 412nm. The 
intensity of this colour, determined spectrophotometrically, is proportional to 
the amount of free cAMP present in the well during the incubation.
Definition of terms
Blank ; background caused by Ellman’s reagent.
Total Activity total enzymatic activity of the acetylcholinesterase linked 
tracer. This is analogous to the specific activity of a radioactive tracer.
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NSB (Non-specific binding) : non-immunological binding of the tracer to the 
well. Even in the absence of a specific antiserum a very small amount of the 
tracer still binds to the well; the NSB is a measure of this low binding.
Bo (Maximum Binding) : maximum amount of the tracer that the antiserum 
can bind in the absence of free cAMP.
%B/Bo (%bound/maximum bound): ratio of the absorbance of a sample or 
standard well to that of the maximum binding (B.) well.
Standard Curve: a plot of the %B/Bq values versus concentrations of a 
series of wells containing various known amounts of cAMP.
Plate Set Up
Each sample was assayed in duplicate. At least two blanks, two maximum 
binding wells (Bo), and two non-specific binding wells (NSB) were included in 
the plate design.
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B - Blank :
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NSB - Non - Specific Binding
B- Maximum Binding
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S1 - S8 - Standards 1 -8  
H - Sample 
Rinse the plates
The wells were rinsed and used once with wash buffer. All of the wash buffer 
was removed from each well before starting the assay. This was 
accomplished by inverting the plate and the last drops were shaken out.
50 pi from tube 0 was added to the NSB and B wells and 50pl of EIA buffer to 
the NSB wells
50 pi of tube 8 was added to both of the lowest standard wells (S8).
50 pi of tube 7 was added to each of the next two standards wells (S7).
This procedure was continued until all the standards were aliquoted.
The same pipette tip was used to aliquot all the standards.
50 pi of of tissue extract sample was now well was added. As was 
recommended, each sample was assayed in duplicate .
50 pi of cAMP Acetylcholinesterase Tracer (cAMP Tracer) was added to each 
well except TA and B wells.
50 pi of cAMP Antiserum was added to each well except TA, NSB and B 
wells.
The plate was covered with the a plastic cover and incubated for 18 hours at 
room temperature.
When the plate was ready to develop, one vial of Ellman’s reagent was 
reconstituted with 20 ml of ultra pure water.. Reconstituted Ellman’s reagent 
was unstable and was used the same day it was prepared. The Ellman’s 
reagent was protected from light when not in use.
The wells were emptied and rinsed five times with wash buffer.
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200 pi of Ellman’s reagent was added to each well and 5 pi of the cAMP 
tracer to TA wells. The plate was covered with plastic film.
Optimum development was obtained by using an orbital shaker equipped with 
a large, flat cover to allow the plate to develop in the dark. This assay 
typically developed in 60-90 minutes.
The plate was read at 412 nm using a plate reader.
Standard Curve Preparation
The cAMP standard was reconstituted with 1 ml of EIA buffer (This was 
labelled standard A). 10 pi of standard A (3000 pmol / ml) was aliquoted into 
9.9 ml of phosphate buffer(This was labeled standard B). This standard was 
stored at 4°C , it will be stable for 4 weeks.
9 test tubes were obtained and numbered 0-8.
500 pi of phosphate buffer was added to tube 0 (this tube was to contain only 
buffer) and tube 2-8.
1 ml of standard B (3 pmol / ml) was added to tube 1.
500 pi of tube was aliquoted into tube 2 and mixed thoroughly.
500 pi of tube 2 (1.5 pmol / ml) was aliquoted into tube 3 and mixed 
thoroughly. This procedure was continued until reaching tube 8.
500 pi of solution in tube 8 was discarded so each tube contained 500pl.
A typical standard curve is shown in fig 2.2.1
Calculation of the results
The plate reader subtracted the absorbance readings of the blank wells from 
the absorbance reading of the rest of the plate. The results were then 
calculated manually as follows:
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The absorbance readings from the NSB wells were averaged.
The absorbance readings from the Bo wells were also averaged.
The NSB average was subtracted from the Bq average. This was the 
corrected Bo or corrected maximum binding.
The %B/Bo (% sample/ standard bound/ maximum bound) was now 
calculated for all the standard wells and for the test wells.
%B/Bo for standard S1-S8 was plotted against cAMP concentration (in 
pmol/ml) on semi log paper.
The concentration of each sample was calculated by identifying the %B/Bo on 
the standard curve and reading the corresponding value on the X-axis.
%B/Bo values greater than15% and less than 80% were regarded as 
acceptable since they generally fell on the standard curve.
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Figure 2.2.1 This standard curve shows %B/Bo for standards 81-88 plotted 
against cAMP concentration (in pmol/ml).
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During preliminary experiments great difficulty was experienced in achieving 
results for the cAMP concentration of incubation mixture which were 
proportional to the volume that was assayed. It appeared that some 
component of the tissue was interfering with the assay. This was confirmed 
by the following experiment:- About 20 pi of the extract (sample) was diluted 
with 480 pi of Kit phosphate buffer to make up the volume to 500 pi, so that 
each sample was diluted to (1 : 25). Then 100pl from each diluted sample 
was again diluted with 400 pi of the Kit phosphate buffer to give a final 
dilution of 1 ; 125.
Standard tubes numbered 0 to 8 were prepared using the non-acetylation 
procedure. The results obtained at the end of this experiment clearly showed 
that the absorbance values of the sample diluted 1 : 125 were in good 
gradation rather than the less diluted sample (1 : 25). For both dilutions, the 
proportionality between cAMP concentration and B/Bo ratio was much closer 
to linear than had previously been found when undiluted homogenate was 
assayed.
This indicated that the more the sample was diluted , the less interference by 
tissue components could occur.
From this experiment we concluded that the acétylation procedure must be 
performed, which allowed assay of less than 10 pmol cAMP.
Before running the acétylation procedure, the samples were therefore diluted 
to 1 : 100 using EIA buffer, hence greatly reducing possible interference by 
components of the incubation mixture in the performance of the assay.
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Acétylation procedure
All samples, as well as standard tubes 0-8, were acetylated so that each 
sample/standard acetylated individually. Care was taken to be consistent in 
acétylation technique as any difference in vortex time and/or delayed addition 
of KOH may result in irreproducible results.
100 pi of 4 M KOH was added and 25 pi Acetic Anhydride in quick 
succession to the first sample, vortexed for 15 seconds.
25 pi of 4 M KOH was added and then vortexed. This was repeated for all 
samples and standard tubes.
(2.2.3) Enzyme-immuno assay of tissue cAMP formation
The tissues from CP and TM were homogenized in a ground glass
homogenizer using phosphate homogenization buffer (sodium phosphate 200 
mM, maleic acid 2 mM, pH 7.4) using 750 pi at a tissue concentration of 240 
mg wet weight ml for CP tissue and 500 pi at a tissue concentration of 160 
mg/ ml for TM. After centrifugation (at 300 xg for 2 min ) to remove large 
pieces of unhomogenized tissue the homogenate was either used 
immediately or stored at -25°C. In order to generate adenylate cyclase 
activity, the conditions for incubation were as described by Tobin and 
Osborne (1993).
Forskolin was included to produce a high level of enzyme activity, in order 
that inhibition by 5-HT or other drugs might be observed.
10 pi of tissue homogenate was added to 85 pi of phosphate incubation 
buffer (sodium phosphate 200 mM at pH 7.4, EGTA,0.2 mM plus 10 pi GTP
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(2.1mM), 10pl forskolin (105pM) and 50pl of phosphodiesterase inhibitor, 
isobutyl methylxanthine (IBMX, 21 mM) was applied and theadenylate cyclase 
activity initiated by adding 25 pi ATP (4.2 mM)
The final concentration of the reagents during incubation was ATP, 500 pM, 
IBMX, 1 mM, GTP, 100 pM and forskolin, 5 pM.
A number of experiments has been carried out to show forskolin stimulation 
and to prove time-dependence.
(A) Forskolin stimulation.
6 test tubes were incubated with different forskolin concentrations (0, 0.5, 1.5, 
5.0, 15, 50 pM) at a constant time of incubation (5 min interval for each 
incubation) to observe only the effect of different concentrations of forskolin 
on cAMP production. A typical curve showing forskolin dependence appears 
as fig 2.2.2
This experiment proved that forskolin-stimulated cAMP production in a dose- 
dependent manner.
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Figure 2.2.2 This curve shows a forskolin-dependent increase in cAMP 
synthesis at a constant time of incubation (5 min).
(B) Time dependence
6 test tubes were incubated with a constant concentration of forskolin (5 pM) 
to facilitate observing the effects of time dependence only. The tubes were 
incubated at different time intervals. This experiment proved that the level of 
cAMP increases with the time of incubation.
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Figure 2.2.3 This curve shows a consistent increase in cAMP synthesis with 
the increase in the time of incubation when a constant concentration of 
forskolin was used (5pM). This curve is typical of four experiments 
demonstrating time dependence.
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In order to determine their effects on the forskolin-stimulated synthesis of 
cAMP, 5-HT and 8-OH-DPAT were tested in three different final 
concentrations (500,50,5 pM) and incubated with both CP and TM.
Adenosine was incubated with CP only, because previously it was tested for 
its effect on lOP only by the intra-arterial route.
Control incubations from CP and TM were prepared and compared with these 
containing 5-HT and 8-OH-DPAT
The assay tubes were incubated in a gently shaking water bath at 37°C for 5 
min. The reaction was stopped by adding 200 pi of 10% trichloroacetic acid 
(TCA).
The tubes then were centrifuged at 10,000 xg for 10 min, to encourage the 
protein to precipitate The supernatant was taken from each test tube (about 
330 pi). TCA was removed by extracting 3 to 4 times with 3 volumes ether 
using the vortex mixer. The tubes were put in a 70°C water bath for 10 min to 
evaporate the remaining ether then stored at -25°C until assay for cAMP.
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(2.3) DRUGS AND CHEMICALS
The following drugs were used in this study:
Adenosine, N®-Cyclohexyladenosine (CHA)-(adenosine Ai receptor agonist), 
N®-(2-(3,5-Dimethoxyphenyl)-2(2-methylphenyl)-ethyl adenosine ( DPMA)- 
(adenosine A2 receptor agonist), ATP, 5-Hydroxytryptamine (5-HT), 8-OH- 
DPAT(5-HT Ai receptor agonist), 5-Carboxamidotryptamine ( 5-CT)
Water was used as a solvent and as control during this research.
Composition of Krebs-Henseleit solution 
(milNMoles per litre)
NaCI, 118 
KCI, 4.7 
Glucose, 11.5 
NaHCOs, 25 
MgS04.7H20. 1.2 
KH2P04, 1.2 
Ascorbic acid, 0.05 
CaCLz
The pH of this solution was adjusted to 7.4 by bubbling with O2 containing 5% 
CO2
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(2.4) EIA CHEMICALS
The materials supplied in the EIA kit were reconstituted as follows Water ;
water used to prepare all reagents and buffers was of trace organic
contaminants (ultra pure) produced by millipore.
(1) EIA buffer ; the contents of this buffer is diluted with 90 ml of ultra pure 
water
(2) Wash buffer ; diluted to total volume of 2 liters with ultra pure water, then 
1 ml of Tween 20
(3) Phosphate buffer : diluted to 50 mM by adding ultrapure water to a final 
volume of 200 ml
(D) : Reagents :
(1) : Ellman’s reagent was reconstituted with 20 ml of ultra pure water
(2) ; KOH diluted to 4 M by diluting the solution with 7.5 ml ultra pure water
(3) : Acetic Anhydride .
(E) : Others:
(1) : cyclic AMP Tracer (cyclic AMP linked covalently to acetylcholinesterase) 
The tracer was reconstituted with 6 ml of EIA buffer.
(2 ): cyclic AMP Antiserum
The antiserum was reconstituted with 6 ml of EIA buffer
56
(3) RESULTS
(3.1) CONTROL VALUES
The pre-injection lOP for all eyes tested by the arterial route (either arterial 
injection or perfusion) (n =127) was: 104.3 ± 9.0mmH2O(mean ±SEM ).
The pre-injection lOP value for all eyes tested by the I.C. route (n=98) was: 
112.4±4.9mmH20.
The pre-injection value for arterial perfusion pressure for all routes (n = 225) 
was 32.1±7.0mmHg.
The mean lOP at the end of the experiments in which vehicle only was 
injected was not significantly different from the pre-injection value, whether 
the injection was intra-arterial or intra-cameral (see table 3.2, first line and 
table 3.4.2, first line). The mean perfusion pressure at the beginning of the 
control experiments was 25.7 ±2.1 mmHg and at the end of the control 
experiments was 26 ± 4.3mmHg (n=15). There was no statistically significant 
difference between starting and finishing values. For statistical method see 
page 41
57
(3.2) Adenosine
In this procedure, single bolus doses of adenosine (Ad), CHA ( an adenosine 
Ai agonist) and DPMA ( an adenosine A2 agonist) were given in volumes of 
1,3 or lOpI (ranging from 3-3000nmol). It was observed that adenosine and 
the other two agonists produce small increases in perfusion pressure only 
seconds after drug administration. This vasoconstrictor effect lasted for 
approximately 10 sec. The peak increase in perfusion pressure was between 
5-10mmH2O for the maximum dose 3000nmol. The effect of these drugs on 
lOP was not significant (P>0.05) when compared with control experiments in 
which water was injected in similar volumes intra-arterially (see table 3.2).
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Table 3.2 Effects on lOP of adenosine (Ad), CHA (selective adenosine Ai 
receptor agonist) and DPMA ( selective adenosine A2 receptor agonist ) given 
as bolus injections into the posterior ciliary artery.
Treat­
ment
Dose(nmol) n Mean IOP(mmH20)±SEM Mean slopeiSEM
Before After
water 9 135.0±6.6 136±6.6 0.036±0.031
Ad 100 4 113±15.8 114±15.2 0.013±0.011
Ad 1000 6 138±5.9 137.8±5.9 -0.002±0.060
Ad 3000 12 121.7±6.1 124.3±6.5 0.041±0.025
CHA 10 9 123.3±8.0 120.5±8.2 -0.041±0.021
30 10 138.1 ±6.0 135.3±6.0 -0.045±0.010
300 9 122.1 ±6.4 120.2±6.5 -0.0296±0.0302
1000 8 125.3±8.4 123.8±8.6 -0.026±0.011
DPMA 3 2 130±26.5 129±26.0 -0.005±0.005
150 5 124.6±9.2 125.2±9.1 0.009±0.010
500 6 106.3±8.6 106.5±8.6 0.002±0.002
The effects of bolus doses of adenosine, CHA and DPMA on lOP in the 
perfused eye, shown as the mean lOP values (in mmHgO) before and 60 min 
after drug injection and as the mean slope of the regression lines on lOP vs 
time ( 60 min ). Each value is a mean ± SEM of the number of experiments 
shown ( n ). None of the slopes differed significantly from the water control 
value (*P>0.05).
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Figure 3.2 Effects of single dose of adenosine for one experiment via an 
arterial injection on the intraocular pressure of the bovine eye. The lOP 
values were stable prior to drug injection. Change in lOP was observed 15 
min after injection. The change in lOP was insignificantly different from 
vehicle-control experiments. P>0.05, n=6.
The calculated slope following drug injection in this experiment was not 
significantly different from that in control experiments.
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(3.3) m e
Data presented in table 3.2 show that bolus arterial injection of exogenous 
ATP (300,1000, and 3000nmol) tested on the isolated bovine eye caused a 
significant effect on lOP in a dose-dependent manner during the 90 min after 
drug administration. The results also demonstrated that ATP produces an 
increase in perfusion pressure immediately after injection. This effect 
appeared within 5 to 10 sec of injection but only persisted for approximately 
40 sec. The peak increase in perfusion pressure was between 60 and 
SOmmHg for the maximum dose of 3000nmol. The effect of this drug on lOP 
was significant (P<0.05) when the slope of lOP against time was compared 
with control experiments using the same route of administration (see table 3 
3) although the magnitude of the decrease was relatively small.
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Table 3.3 Effects on lOP of exogenous ATP given as bolus injection into the 
posterior ciliary artery.
Treat­
ment
Dose (nmol) n Mean IOP(mmH20)±SEM Mean
SlopelSEM
Before After
Water
Control
9 135.0±6.6 136.4±6.6 0.036±0.031
ATP 300 8 114.6±3.4 112.6±3.9 -0.0178±0.1271
1000 7 109.7±4.1 105.3±3.7 -0.0483±0.0141*
3000 6 111.3±5.1 106.1 ±4.9 -0.0591 ±0.0152*
The effects of bolus doses of ATP in the isolated perfused eye, shown as the 
mean lOP values ( in mmHzO) before and 90 min after drug injection and as 
the mean slope of the regression lines on lOP vs time (90 min). Each value 
is a mean±SEM of the number of experiments shown (n). Significance of 
difference from the water control values: *P< 0.05.
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Figure 3.3 This histogram shows a graded dose-response relationship for 
the decrease in lOP when ATP was injected into the bovine posterior ciliary 
artery. Increases in lOP are expressed as the mean slope of the regression 
lines
on lOP vs time (90 min) Each value is a mean ± SEM of the number of 
experiments shown (n). Probability (P) refers to the difference in slope 
between each dose of the drug and the slope of the water control. For 
statistical method, see page 41.
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(3.4) 5-HT
3.4,1 Intra^arterial injection and perfusion
Intra-arteria! injection of lOnmol 5-HT into the posterior ciliary artery 
produced no effect on perfusion pressure
We also found that 5-HT did not have any significant effect on lOP (80 min 
after drug administration ). For this reason we tested the effect of 5-HT by 
arterial perfusion may, accumulate to a higher concentration as the drug will 
stay longer in the ciliary body and might produce a significant effect on lOP. 
Different concentrations of 5-HT were added to the Krebs’ solution (10^, 
2x10"® M). We found that 5-HT again produced no effect on perfusion 
pressure. When lOP values were recorded before and 90 min after drug 
administration, it was found that 5-HT does not produce a significant effect on 
lOP when compared with water control lOP values (see table 3.4.1).
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Table 3.4.1 Effects on lOP of 5-HT , using arterial routes of
administration.
Route Treat­
ment
Dose(nmol) or 
conc(Molar)
n Mean IOP±SEM Mean
Slope+SEM
Before After
IA.Inj water 9 135±6.6 136±6.6 0.036+0.031
IA.Inj 5-HT lOnmol 3 115.7±7. 117.7+9.0 0.0164+.0.050
Art.Per 5-HT 10‘‘ M 5 104.2±2.0 104.0+2.0 -0.0019+0.024
Art.Per 5-HT 2xlO'‘M 6 100.7±2.8 99.3 ±1.8 -0.0175± 0.012
The effect of the drug ( administered by the routes indicated ) on lOP in the 
perfused eye are shown as mean lOP values recorded ( in mmH20) before 
and 90 min after drug injection and as the mean slope of the regression lines 
on lOP vs time (90 min). Each value is a mean ± SEM of the number of 
experiments shown (n). Routes of administration: arterial injection (I A.inj); 
arterial perfusion (Art.per). None of the slopes differed significantly from the 
water control value.
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3.4.2 Intracameral route
The above experiments with 5-HT using arterial routes, indicated that this 
drug has no effect in modulating bovine lOP. In contrast, a statistically 
significant decrease in lOP was observed when this drug was administered 
by the intracameral route.
A single bolus injection of 5-HT was given in volumes of 1, 3 or lOpI, ranging 
from 3-100nmol and tested on perfusion pressure and lOP of the bovine 
isolated perfused eye.
This drug produced small transient increases in arterial perfusion pressure in 
a dose- dependent manner.
The drug effects were compared with data from control perfusions in which 
water was injected in the same manner (see table 3.4.2).
A very small decrease in lOP occurred when bolus injection of 3nmol 5-HT 
was given but this was statistically insignificant (P>0.05). The doses of 10 
and 30nmol 5-HT produced dose- dependent decreases of lOP (P<0.05). 
When bolus injection of lOOnmol was administered, it was found that this 
dose appeared to lower lOP, though the effect was statistically insignificant 
(P>0.05).
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Table 3.4.2 Effects on lOP of 5-HT given as bolus injection into the 
anterior chamber.
Treat­
ment
Dose
(nmol)
n Mean lOP+SEM Mean
Slope+SEM
Before After
Water
Control
6 107.8+2.4 107.3+2.4 -0.0030±0.006
5-HT 3 9 113.1±6.2 111.0±5.9 -0.0258±0.011
10 8 109.8+5.6 105.9±5.7 -0.0387±0.008*
30 9 110.0+6.7 105.2+6.8 -0.0538±0.007*
100 8 108.5+3.0 105.3+3.2 -0.0321+0.018
The effects of bolus doses of 5-HT in the bovine isolated eye, shown as the 
mean lOP values (mmHgO) before and 90 min after drug injection and as the 
mean slope of the regression lines on lOP vs time (90 min). Each value is a 
mean ±SEM of the number of experiments shown (n). Significance of 
difference from control: *P<0.05.
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Figure 3.4 Histogram representation of 5-HT dose-dependence
This histogram shows the dose-dependent relationship for the decrease in 
lOP when 5-HT which was administered intra-camerally to the perfused 
bovine eye. It was clear from this histogram that these responses were dose- 
dependent up to the SOnmol level. But that the lOOnmol dose was less 
effective.
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(3.5) 8-OH-DPAT
3.5.1 Intra-arteriaiinjection
The present work tested the effects of 8-OH-DPAT on the bovine lOP using 
different molar concentrations (10^, 2x10^, 3x1 O'® M) by arterial perfusion 
and it was found that the drug produces no effect on arterial perfusion 
pressure nor on lOP when compared with water control experiments using 
the same route of administration. This was true whether the comparison was 
done on lOP values before and after 90 min perfusion, or on the slopes of 
lOP against time.
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Table 3.5.1 Effects on lOP of 8-OH-DPAT using arterial perfusion
route of administration.
Treatment conc(M) n Mean lOP+SE M(mmH20) Mean Slope+SEM
Before After
Water
Control
9 135.0+6.6 136+6.6 0.036+0.031
8-OH-DPAT 10^ 4 103.5+2.3 100.3+3.2 -0.0357 + 0.031
8-OH-DPAT 2x10 2 106.0+6.0 106.5+6.5 0.0053 + 0.010
8-OH-DPAT 3x10 4 104.0+3.7 104.0+3.7 0.00023 +0.331
The effect of the drug ( administered by the route indicated ) on lOP in the 
perfused eye are shown as mean lOP values recorded ( in mmH2Û) before 
and 90 min after drug injection and as the mean slope of the regression lines 
on lOP vs time (90 min). Each value is a mean ± SEM of the number of 
experiments shown (n). None of the slopes differed significantly from the 
water control values: *P>0.05.
3.5.2 Intracameral injection
Single bolus doses of 8-OH-DPAT given in volumes of 1, 3 or 10pl (ranging 
from 3-100nmol) using intracameral injection were tested on perfusion 
pressure and lOP and it was found that 8-OH-DPAT produces no effect on 
perfusion pressure, but produces a significant decrease in lOP when values 
were taken before and 80 min after drug administration are compared with 
water control lOP values.(see table 3.5.2 and fig 3.5.)
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Table 3.5.2 Effects on lOP of 8-OH-DPAT using I.C route of administration.
Drug Dose
(nmol)
n Mean IOP(mmH20)±SEM Mean Slope+SEM
Before After
Water 6 107.8+2.4 107.3+2.4 -0.0030+0.006
8-OH-DPAT Snmol 8 118.4+5.4 112.0+5.4 -0.0907+0.014*
8-OH-DPAT lOnmol 10 105.2+4.4 100.0+4.0 -0.0670+0.023*
8-OH-DPAT 30 nmol 7 126.8+6.4 117.2+5.2 -0.1193+0.022***
8-OH-DPAT lOOnmol 7 118.1+8.0 109.1+8.0 -0.1151+0.020**
The effect of 8-OH-DPAT ( administered by the I 0  route ) on lOP in the 
perfused eye are shown as the mean lOP values recorded ( in mmH2Û) 
before and 90 min after drug injection and as the mean slope of the 
regression lines on lOP vs time (90 min). Each value is a mean ± SEM of the 
number of experiments shown (n). Significance of difference from control : 
*P< 0.05, **P< 0.01, ***P< 0.001.
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Figure 3.5. Histogram representation of 8-OH-DPAT dose-dependence 
While all doses tested showed that 8-OH DRAT causes a decrease in lOP, 
there was little evidence of dose-dependence.
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(3.6) 5-CT
In an in vitro model, the present study clarifies the role of 5-CT in the 
modulation of ocular function In the bovine eye.
Single bolus injections of 5-CT intracamerally were given in volumes of 3,6 
and 20pL (20,60 and 200nmol) and tested on perfusion pressure and lOP of 
the bovine eye. Effect of 5-CT was observed on perfusion pressure. On the 
other hand 5-CT causes a statistically significant decrease in lOP in a dose- 
dependent manner compared with data from control experiments using water 
injected I.C. (see Table 3.6).
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Table 3.6 Effects on lOP of exogenous 5-CT given as bolus injection into the 
anterior chamber
Drug Dose(nmol) n Mean IOP(mmH20)±SEM Mean SlopelSEM
Before After
Water 6 107.8+2.4 107.3+2.5 -0.0030+0.006
5-CT 20 9 108.3±4.7 104.8±4.5 -0.0407±0.008*
60 9 113.8+3.5 109.8±4.2 -0.0556±0.021*
200 8 117.8+7.0 105.1±6.9 -0.1405±0.017***
The effects of bolus doses of 5-CT in the isolated perfused eye, shown as the 
mean lOP values ( in mmH20) before and 90 min after drug injection and as 
the mean slope of the regression lines on lOP vs time (90 min). Each value 
is a mean ± SEM of the number of experiments shown (n). Significance of 
difference from the water control values: *P< 0.05; ***P< 0.001.
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Figure 3.6 Histogram representation of 5-CT dose-dependence 
This histogram showed a dose-dependent decrease of lOP when 5-CT 
was given I.C.
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(3.7) Cyclic AMP
Forskolin is well established in its ability to stimulate cAMP synthesis without 
interacting with cell surface receptors. In the present work, this agent was 
added to stimulate cAMP production.
Preliminary experiments showed that forskolin increases cAMP production in 
a concentration-dependent and time-dependent manner (see figs 2.2.2 and 
2.2.3).
For an incubation period of 5 min, maximum stimulation of 3.8 pmol cAMP / 
mg tissue is achieved by 50 pM forskolin. In subsequent experiments, a 
constant concentration of 5 pM forskolin was used, where small changes in 
forskolin-stimulated activity will manifest the greatest difference in cAMP 
production.
With a forskolin concentration of 5 pM to stimulate adenylate cyclase there is 
a linear relationship between incubation time and cAMP production up to 15 
min. The production rate is greater than 3 pmol/ mg tissue/ 5min.
The level of cAMP synthesis increases over 15 min incubation period, but at 
a much slower rate. As the relationship is linear, the time of 5 min forskolin 
stimulation in each incubation was chosen, because it produces cAMP 
amounts which were within the range and accurately determined by the 
enzyme-immuno assay. Control levels of forskolin-stimulated cAMP 
production in TM (around 20 pmol/mg prot/5 min) were considerably higher 
than in CP (approximately 5 pmol/mg prot/5 min).
Adenosine (500, 50 pM) failed to produce change in cAMP of the CP 
homogenates, as shown in table 3.7.1.
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The effects of multiple concentrations of 5-HT or 8-OH-DPAT (500, 50, 5 pM) 
were studied on forskolin-stimulated cAMP production in the bovine CP and 
TM homogenates. Both 5-HT and 8-OH-DPAT caused a non-significant 
increase in cAMP level compared to the control values, as shown in tables
3.7.2 and 3.7.3.
Table 3.7.1 Effects of Adenosine on forskolin (5pM) stimulated cAMP 
production in homogenates of ciliary processes of the bovine eye. The 
incubations were each conducted twice (homogenates A and B). Each 
incubation mixture was assayed in duplicate or triplicate.
Treatment Concentration
(pM)
Tissue cAMP production 
pmol /mg protein
Control CP(A) 3.3
Ad 500 CP(A) 6.6
50 CP(A) 2.15
Control CP (B) 6.72
Ad 500 CP (B) 8.13
50 CP (B) 10.17
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Table 3.7.2 Effects of 5-HT on forskolin (5pM) stimulated cAMP production 
in homogenates of trabecular meshwork (TM) and ciliary processes(CP) of 
the bovine eye. The incubations were each conducted twice (homogenates A 
and B). Each incubation mixture was assayed in duplicate or triplicate.
Treatment 5-HT Cone 
(pM)
Tissue cAMP production 
pmol /mg protein
Control TM(A) 18.3
5-HT 500 TM(A) 22.5
50 TM(A) 308
5 TM(A) 25
Control TM (B) 13.7
5-HT 500 TM (B) 26.3
50 TM (B) 23.2
5 TM (B) 38
Control CP (A) 3.3
5-HT 500 CP (A) 5.7
50 CP (A) 4.6
5 CP (A) 5.88
Control CP (B) 6.72
5-HT 500 CP (B) 5.2
50 CP (B) 6.72
5 CP (B) 8.21
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Table 3.7.3 Effects of 8-OH-DPAT on forskolin (5pM) stimulated cAMP 
production in homogenates trabecular meshwork and ciliary processes of the 
bovine eye. The incubations were each conducted twice (homogenates A 
and B). Each incubation mixture was assayed in duplicate or triplicate
Treatment Concentration
(pM)
Tissue cAMP production 
pmol /mg protein
Control TM(A) 18.3
8-OH-DPAT 500 TM(A) 16.7
50 TM(A) 14.8
5 TM(A) 11.5
Control TM (B) 13.7
8-OH-DPAT 500 TM (B) 20
50 TM (B) 31.5
5 TM (B) 26.3
Control CP (A) 3.3
8-OH-DPAT 500 CP (A) 5.0
50 CP (A) 4.6
5 CP (A) 2.15
Control CP(B) 6.72
8-OH-DPAT 500 CP (B) 8.21
50 CP(B) 8.21
5 CP (B) 0.04
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(4) DISCUSSION
(4.1) Introduction
The bovine perfused eye offers a useful method for studying the mechanisms of 
action of drugs on lOP and aqueous humour formation without the necessity to 
kill animals for experimental purposes. In addition to that it is readily available 
and cheap. Although Kishida et al, (1985) expressed doubts about its potential 
usefulness, this model has allowed considerable success in demonstrating drug 
effects on lOP and aqueous humour dynamics in  v itro  (Wilson et al, 1995). 
Control values for iOP and perfusion pressure in the present work are similar to 
previously published data from this preparation (Wilson et al, 1993).
(4.2) Adenosine
This is the first study to test the effect of adenosine and its receptor agonists 
(CHA and DPMA) on the IOP of the bovine eye.
Adenosine and its receptor agonists have been shown to modulate a variety of 
physiological functions, however little is known about the role of these receptors 
in the modulation of ocular function .
The present study revealed that neither adenosine nor CHA nor DPMA was 
effective in altering IOP when given by the intra-arterial route. They produced 
small transient increases in the perfusion pressure. This was probably because 
of a vasoconstrictor effect on the uveal vasculature. The lack of the effect on 
IOP in contrast with the previous study by Crosson and Gray (1994), who 
investigated and evaluated the potential role of adenosine and some of its 
analogues in modulating IOP in rabbit. The compounds tested were: the Ai 
agonist, N^-cyclopentyl adenosine (CPA), the non- selective adenosine agonist,
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5’-N-ethyl carboxamide adenosine (NECA) and the A2 agonist, 8-phenyl amino 
adenosine (CV-1808). They observed that topical administration of NECA 
produced a dose- related reduction in IOP. However, an initial ocular 
hypertension of 1 to 2 hours was also observed in rabbits treated with NECA. 
The administration of the A2 agonist produced only initial ocular hypertension. 
These results indicate that selected adenosine agonists can modulate IOP at 
least in the case of the rabbit. Adenosine Ai receptors have been shown to be 
negatively coupled to adenylate cyclase in several systems and CPA was found 
to suppress cAMP formation in the isolated iris and ciliary body 
The ocular hypotension induced by these agonists is consistent with the 
activation of adenosine Ai receptors and may involve the reduction of cAMP 
levels in the iris/ciliary body, (Crosson and Gray, 1994).
Tian, Gabelt, Crosson and Kaufman (1997) investigated the effects of single 
or multiple topical doses of the relatively selective Ai receptor agonists (R) - 
phenyl isopropyl adenosine (R-PIA) and (CHA) on IOP, aqueous humour flow 
and outflow facility in the ocular normotensive cynomolgus monkeys. IOP, 
aqueous flow and outflow facility were determined under specific experimental 
conditions. They found that a single unilateral topical application of R-PIA or 
CHA produced ocular hypertension (maximum rise 4.9 or 3.5 mmHg) within 30 
min, followed by ocular hypotension (maximum fall = 2.1 or 3.6 mmHg) from 2-6 
hr Neither R-PIA nor CHA clearly altered aqueous flow. Total outflow facility 
was increased by 71% after R-PIA topical application.
In conclusion, the early ocular hypertension produced by topical adenosine 
agonists in cynomolgus monkeys is associated with the activation of adenosine
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A2 receptors, while the subsequent hypotension appears to be mediated by
adenosine Ai receptors and resulted primarily from increased outflow facility
(Tian, Gabelt, Crosson and Kaufman,1997).
The difference in results between the present work and those reported by these 
other workers probably because of using different species (bovine in contrast 
with rabbit and monkey) and perhaps also of the influence of different routes of 
administration on the effect of the drugs on ocular function. The use of different 
routes would lead to different absorption in the eye and therefore different 
access to sites of action, which may affect the drug effects on IOP. This would 
be particularly true if a drug^ affected IOP by an action on the drainage 
meshwork. This tissue is readily accessible to topically administered drugs, but, 
since it is avascular, it is relatively inaccessible to drugs administered by the 
intra-arterial route.
(4.3) ^
The increase in perfusion pressure produced by exogenous ATP was probably 
due to its strong constriction of the ciliary blood vessels. This action was very 
short and lasted only for 1-2 minutes (because of its rapid destruction by the 
ATPase enzyme). For this reason it is unlikely to have any lasting effect on IOP. 
Small doses of ATP produced an insignificant lowering effect on IOP and a 
significant effect was observed only when a large dose of ATP was used.
It has been shown that ATP and DTP cause an increase in intracellular Ca^^ in 
cultured bovine ciliary epithelium (Wilson and Shahidullah, 1995). Increase in 
cytosolic Ca^  ^has also been reported for noradrenaline and carbachol in rabbit 
ciliary epithelium (Yoshimura et at, 1995) and histamine, thrombin and
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neuropeptides in human non-pigmented ciliary epithelium (Crook and 
Polansky, 1992), but no physiological significance of these observations has 
been put forward. There may be great significance in the recent observations 
(Wilson and Shahidullah, personal communication): (i) that terbutaline (which 
suppresses aqueous humour formation in the bovine eye) decreases the peak 
value of the Ca^* transient and elevates and prolongs the plateau phase of the 
Ca^ "^  response to ATP and (ii) that sodium azide or atriopeptin (both of which 
have been found to suppress aqueous humour formation) also inhibit this Ca^  ^
response to ATP, although in a subtly different manner from terbutaline. 
Secretion in the ciliary epithelium may be regulated by the combined 
effect/interaction of multiple receptors (Wax, 1992). Thus it can be postulated 
that cAMP, cGMP and Ca^  ^may all play a part in modulating aqueous humour 
formation.
The major finding of the experiments in the present work is that exogenous ATP 
by arterial injection has lowered IOP in the bovine eye . Among the possible 
mechanisms by which ATP has lowered the IOP, is an effect on aqueous 
formation in the ciliary epithelium which may be connected with its effects on 
intracellular Ca^  ^described above).
The mechanism of this effect on ATP seems to be that it is acting on P2 Y2 
receptors in the ciliary epithelium (Shahidullah and Wilson, 1997), thereby 
releasing Ca^  ^from intracellular stores. Much work remains to be done to show 
links between intracellular Ca^* and the ion pumps and channels which are 
responsible for aqueous humour formation. Further study of this action may help 
towards discovering these links.
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(4.4) 5-Hydroxytryptamine
Meyer-Bothling, (1993) found that topical application of exogenous 5-HT or the 
5-HT1-like agonist, 5-CT, increases IOP in rabbit. They also found that the 5- 
HTia receptor agonist, 8-OH-DPAT, causes a decrease in rabbit IOP when 
applied topically. But they couldn’t provide a better understanding of how 5-HT ia 
receptors are involved in the regulation of IOP. From these results we may 
conclude that the 5-HT ia receptor in the rabbit is responsible for decreased IOP, 
whereas some other 5-HT receptor(s) appear to mediate increased IOP. 
Osborne et at. (1987) suggested that the increases in rabbit IOP may be 
caused partly or entirely by an increase in aqueous secretion mediated by 5- 
HTi-like receptors. However no evidence was adduced to support his proposal. 
In the case of these opposing drug effects , we have little clue as to whether they 
involve an effect on formation or drainage of aqueous humour (or perhaps 
both).
The present work shows that exogenous 5-HT or 8-OH-DPAT by the arterial 
route (either bolus or continual perfusion) have no effect on IOP in the bovine 
isolated eye, while both these drugs have a lowering effect on bovine IOP when 
given by I.C injection. These results could lead to the conclusion that the route 
of administration has a significant influence on the effect of 8-OH-DPAT and 5- 
HT in modulating IOP. The fact that the I.C. route is effective while the arterial 
route is not, may indicate that the site of action of both drugs may be the 
trabecular meshwork, rather than the ciliary body.
Intracameral injection delivers the drug directly to the anterior chamber and, 
after a short delay for mixing in the aqueous, it will be carried into the meshwork
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by flow of aqueous and there may cause an increase outflow facility. Arterial 
perfusion, although it rapidly reaches the ciliary body, does not deliver a drug 
quickly to the trabecular meshwork, since it is avascular. The drug can only 
reach the meshwork by a circuitous route, diffusing through the iris / ciliary body 
or by entering the posterior chamber and travelling with the flow of aqueous 
humour to the anterior chamber and then the drainage pathway. The observed 
decrease in lOP caused by I. C 5HT or 8-OH-DPAT may therefore indicate that 
they increase the facility of outflow. Moreover it appears from the results 
obtained in the present work and those of Osborne et al,(1996), that topical and 
I.e. injection of 8-OH-DPAT have similar effects on lOP, despite the different 
species involved (bovine and rabbit). This similarity supports the idea that 8- 
OH-DPAT is affecting an anterior rather than a posterior chamber structure, i.e. 
perhaps the trabecular meshwork. From this we may also conclude that topical 
application and I.C. injection are similar to each other. This similarity allows us 
to suggest that there may be no species variation between bovine and rabbit at 
least in relation to 5-HT ia receptor-mediated effects on lOP.
Other workers ( Krootila, Uusitalo and Palkama, 1987) have reported that 
topical 5-HT application of 2% 5-HT caused a decrease in lOP in rabbits, 
whereas an I.C. injection of the drug caused a rise in rabbit lOP. They 
suggested that the differences between the responses to topical and I.C. 5-HT 
could be from variations in the concentration of the amine at different sites of 
action. I.C. 5-HT might, for example, be of a sufficient concentration to cause an 
inflammatory response, whereas topically applied amine reaches the level where 
it may have an action on adrenergic nerves (i.e increasing the outflow of
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aqueous humour through increasing the release of noradrenaline from the 
adrenergic neurons). This was similar to the report of Meyer-Bothling, Bren 
and Osborne, 1993).
Receptor binding experiments have shown that 5-CT and 8-OH-DPAT were the 
compounds showing highest affinity for the 5-HT ia receptors in the rabbit iris- 
ciliary processes (Chidlow et al, 1995), thus since they are both agonists it is 
surprising that they appear to have opposing effects on lOP. It is possible that 
the two compounds have different rates of penetration through the cornea or 
different routes of entry into the eye and consequently separate sites of action. 
More likely, the explanation is that 5-CT is known to have affinity for receptors 
other than 5-HT ia (Alexander and Peters, 1998) and activation of these other 
receptor types (5-HTs, 5-HTe, 5-HT?) might produce ocular hypertensive effects 
which could override the effects on 5-HT ia receptors.
5-Hvdroxvtryptamine by I.C route
Chiang et al., (1974) found a decrease in the lOP of dogs and rabbits after 
intravenous injection of 5-HT. In contrast, More et al, (1981) reported no 
change in lOP after treatment with 5-HT by intravitreous injection. From his 
pharmacological point of view, Moro suggests that the absence of 5-HT effect 
that he found in the eye could be correlated with a simple depletion of 
catecholamine (i.e., to a lysis of the sympathetic ocular tone) Similarly, neither 
did Chiou et al, (1985) find a change in the lOP after topically or intracamerally 
administered 5-HT in rabbit.
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However, Krootila et al, (1987) reported a decrease in the lOP (measured with 
pneumatonometer) after topical application of 5-HT and an increase in the lOP 
(measured electromanometrically with an intracameral needle) after 
pentobarbital anesthesia following I.C. injection of 5-HT.
In summary then, the literature on this subject is full of controversy.
It is worth noting in this context, however, that pentobarbital anesthesia itself has 
an effect on lOP ( Meyer-Bothling et al, 1993). This could influence some of 
the data reported because some of the experiments on I.C administration of 5- 
HT were carried out in animals anaesthetized with pentobarbital.
Topical application of different concentrations of 5-HT to rabbit eyes revealed a 
dose-dependent, statistically significant increase in the iOP over at least a 2 
hours period (Meyer-Bothling et al., 1993).
Moreover, recent studies by Chidlow and coworkers (1995) have shown that 
topical application of 5-HT increases IOP in rabbit. Although topical and I.C. 
routes would seem to deliver the drug to the same site of action, it is surprising 
that both of the drugs have different effects on IOP.
The present work has shown administration of 5-HT by arterial routes has no 
effect on the bovine IOP. This route is convenient in vitro, but very difficult in 
wVo. The pattern of drug distribution clearly differs from that resulting from 
topical administration or I.C. injection. To determine whether 5-HT could 
modulate IOP when delivered primarily to the anterior chamber, the present 
study was extended to include injection of 5-HT using the I.C. route. Here it was 
found that 5-HT caused a significant reduction of IOP in a largely dose- 
dependent manner.
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The results that were obtained in the present work have confirmed the previous 
proposal that the mechanism by which both 8-OH-DPAT and 5-HT could 
modulate the bovine IOP is more likely to be through their effect on the outflow 
facility, as the I.C. route delivers the drug directly to the trabecular meshwork but 
does not deliver the drug to the ciliary body (at least, not nearly so efficiently as 
by arterial injection or perfusion).
It is not clear if the difference in the results obtained by the present work and 
these reported by Chiang et al. (1974), Moro et al. (1981), Chlou et ai (1985), 
Krootila et al (1987), Meyer-Bothling et al (1993) and Chidlow et al (1995)
relate to the dissimilar experimental conditions, different drug concentration, 
species variations, in  vivo and  in  vitro  situation or to some other factors.
For any set of conditions decided upon there is some variability in the results, so 
there is a need to carry out many experiments under controlled conditions to 
obtain a consensus.
(4.5) 5-Carboxamidotryptamine
Previous workers demonstrated that intravitreal injection of the 5-HTi-agonist, 5- 
CT (Tormay, Severin and MIttag, 1985), or topically applied 5-CT (Meyer- 
Bothllng et al., 1992: Meyer-Bothllng, Bron and Osborne, 1992) increases 
IOP in rabbits, thus suggesting that 5-HTi-like receptors exist on the ciliary 
processes and or/trabecular cells. Moreover, in their studies Meyer-Bothllng et 
al. (1993) and Chidlow et al. (1995) reported that topical application of 5-CT to 
the rabbit eye caused an increase in IOP with time course similar to 5-HT but 
with greater efficacy.
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This demonstrates that 5-CT penetrates the cornea and possibly activates 5-HTi 
receptors more effectively than 5-HT itself. This is the first reported evidence of 
a 5-HT-agonist influencing IOP (Meyer-Bothling et al, 1993). Their evidence 
suggests that the rise in IOP was not caused by a breakdown of the blood- 
aqueous barrier, but may have been caused by an increase in aqueous 
formation mediated through 5-HTi-like receptors (Chidlow et al, 1995).
In contrast to the results obtained by the previous workers; the present work 
demonstrates significant decrease in IOP of the bovine eye when 5-CT is used 
by the intracameral route. The mechanism of action of 5-CT in lowering the 
bovine IOP is probably through the activation of 5-HTi-like receptors but clearly 
differs from that which occurs in the rabbit eye.
In this study, the present work addressed and sequenced a number of important 
points concerning factors that might influence the effect of 5-CT in the 
modulation of ocular function.
(i) The route of administration
The similarity in the results obtained by Tormay et al., 1985 and Meyer- 
Bothling et al., 1993, indicate that the use of different routes of administration 
has no influence on the effect of 5-CT on the regulation of IOP at least in the 
case of rabbit eyes.
The present data suggested that 5-HT and 8-OH-DPAT have no effect on IOP in 
the bovine eye when used by arterial perfusion and injection. For this reason 5- 
CT has not been tested by the arterial routes and was only used by the I.C. 
injection
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(ii)The dose of the drug
The use of different doses of 5-CT might give a clue to the dissimilar results 
obtained by the present work and the other workers. The use of different doses 
of the amine favours to different sites of action. The present work used lower 
doses of 5-CT (20, 60, 200nmol), which may be enough to activate 5-HT ia 
receptors. Other workers (Meyer-Bothling et al., 1993) used higher doses of 5- 
CT (300, 600, 1200nmol) that may activate other 5-HTi receptor subtypes 
responsible for the ocular hypertensive effects of this drug and that could over 
ride its effect on 5-HTia receptors.
(iii) Species variation and experimental variation
The data suggested that both species differences and experimental differences 
may influence the effect of the amine on the regulation of IOP and might explain 
and clarify the dissimilarity of the results obtained by different workers. This is 
because in vivo work involves the influence of the central nervous system and 
hormonal and vascular systems, which often complicate the interpretation of 
results.
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(4.6) CAMP
This section of the project attempted to make a correlation between the effects of 
the drugs under study on IOP and their effect on cAMP production in tissue 
homogenates of the bovine eye. This has been done by measuring the cAMP 
formation rates in CP and TM in the present of 5-HT and related drugs, using 
the recently developed enzyme-immuno assay technique.
The diversity of assays available for adenosine 3’,5’-cyclic monophosphate are 
impressive and highly desirable. Analytical difficulties are imposed by extremely 
low tissue levels of the cAMP and considerably higher levels of potentially 
interfering compounds. The existence of several good techniques for estimation 
of quantities of cAMP in biological material ensures the fact that different 
laboratories will be subject to different sets of limitations and possible errors. 
The ultimate result should thus be beneficial (Gilnnan, 1972).
The main advantage of EIA assay is sensitivity, especially when it is used with 
acétylation procedure. Only by using acétylation was it possible to measure the 
very small amounts of formed in CP and TM homogenates.
We could not compare the control values of the present work with other worker's 
control because of lack of literature.
The cAMP assay was clearly sensitive to interference by substances present in 
the tissue extracts and hence we had to use high dilutions of the tissue 
homogenates, assayed using the acétylation technique.
The assay results show rather a high variability, and so much repetition of these 
experiments would be necessary before reliable results could be obtained. 
Unfortunately, the assay Kit was too expensive to permit more than two
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measurements of each drug concentration on each tissue, despite this
limitation, some interesting trends in the results can be seen.
Even allowing for the variability of the data, cAMP production in TM seems to be 
more than three times greater than in CP.
Results from the present showed no effect of adenosine on cAMP formation 
rate. This finding is compatible with our failure to observe any change in IOP in 
the bovine eye.
In CP homogenate, 5-HT produced inconsistent results (Table 3.7.2) with some 
apparent increases occurring, but with no sign of concentration-dependent 
changes. This again is at least compatible with the IOP results for 5-HT by 
arterial routes (Table 3.4.1) where the drug concentration is likely to be much 
higher in the ciliary body than in the drainage meshwork.
The most convincing result among the cAMP data is that in which the formation 
rate in TM is increased by 5-HT in every case (i.e. in tissues samples A and B, 
and at every concentration of 5-HT). This implies that 5-HT is activating 
adenylate cyclase (although it has to be admitted that the effect is not 
concentration dependent). Such an increase in cAMP formation implicates not 
5-HTi receptors (which are linked to Gj protein and inhibition of adenylate 
cyclase) but rather perhaps 5-HTs, 5-HTe or 5HTt receptors (which are linked to 
Gs and stim ulation  of adenylate cyclase). Some support exists from receptor 
binding experiments that 5HTy receptors are located in the rabbit anterior eye 
(Chidlow et al, 1995).
p-adrenoceptors also act by stimulating adenylate cyclase. Activation of these 
receptors in the outflow apparatus is thought to be the mechanism by which
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adrenaline lowers IOP both in the rabbit (Anderson and Wilson, 1990) and in 
man (Erickson-Lamy and Nathanson, 1992). It is this very likely that 
adrenaline lowers IOP by increasing cAMP formation in the TM.
By analogy with adrenaline, 5-HT by the I.C route in the bovine eye may lower 
IOP by activating 5-HT receptors linked to Gs, which would stimulate cAMP 
formation leading to an increase in the facility of outflow of aqueous humour and 
a decrease in IOP.
The results for 8-OH-DPAT effects on cAMP showed some consistency, since in 
both CP homogenates (A and B), this drug appeared to inhibit cAMP synthesis 
at the lowest concentration (5^iM) while increasing cAMP at higher 
concentrations (50 and 500 pM).
Such a biphasic pattern of effect is not necessarily impossible, since we know 
that some 5-HT receptors are inhibitory while others stimulate adenylate 
cyclase. It is possible, therefore, that 8-OH-DPAT at higher concentrations, 
might activate another receptor, e.g. 5-HTs, 5-HTe or 5 -HT7, all of which are 
linked to Gs protein. Any of these receptors might lead to an increased cAMP 
production.
8-OH-DPAT appeared to produced different effects on both TM homogenates (A 
and B). In the case of TM homogenate (A), 8-OH-DPAT decreased cAMP 
production with apparent concentration-dependence. However, in TM (B) 8-OH- 
DPAT produced an opposite effect with no-concentration dependency. No 
conclusion can therefore be drawn from these results.
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Previous studies by Tobin and Osborne (1993) showed that 5-HT and 8-OH- 
DPAT reduced the forskolin-stimulated cAMP formation in the rabbit iris-ciliary 
body, suggesting the presence of 5-HTi-like receptors.
Although an inhibition or stimulation of basal cAMP levels was seen in tissue 
homogenates following exposure to serotonin. These authors observed that it is 
of significance that the inhibitory effects of 5-HT ia receptor agonist, 8-OH-DPAT 
on adenylate cyclase
activity are greater in the ciliary process than in the iris muscle.
The ciliary processes are associated with the production of aqueous humour and 
this process is cAMP dependent (Sears et al, 1984; Bartels, Lee and Neufeld, 
1987). The possibility of 5-HTia receptor being involved in the formation of 
aqueous humour and therefore the regulation of IOP must be considered.
In view of the different patterns of results in the tissues of various species, it 
would appear that the effects of 5-HT and 8-OH-DPAT on IOP and cAMP level 
may vary from one species to another. This could explain the dissimilar results 
obtained by different workers. Some of the conflict in the results may also vary 
because of the use of different routs of administration and other experimentable 
variables, including drug dosage. The present work has demonstrated an ocular 
hypothensive effect of ATP for the first time and has added to the existing 
evidence that some 5-HT analogues can lower IOP. The evidence that the later 
effects seem to be mediated via an effect on outflow requires confirmation by 
direct measurement.
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